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Comprehensive Sequencing with Surface Tagmentation Based Technology
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ABSTRACT
Next-generation sequencing technologies (NGS) have undergone extensive
improvements since the invention of the 454 sequencing system in 2005. With
tremendous progress in throughput, speed and a dramatic reduction in per-base
cost, DNA sequencing is widely used in basic science as well as translational
research. However, it is still a challenge to acquire a complete human genome.
The long-range information is often missing due to the short length of NGS reads,
which leaves many gaps in between scaffolds rather than an entire piece for each
chromosome. Moreover, without the long-range information, haplotype-resolved
genome sequencing and structural variant detection can be difficult, however, it is
critical to understand the genetic basis of complex phenotypes with haplotype
information. These complex structural genomic variations are often involved in
numerous diseases, such as cancer. Here we developed a novel method to
provide a more complete human genome sequence and allow genome studies to
accurately identify all variants and phase them to the appropriate homologous
chromosome. Ultimately, our approach can decrease the cost of whole genome
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sequencing while dramatically increasing the accuracy and completeness of the
sequencing.

In the first chapter, I overviewed the current DNA sequencing technologies,
compared short-read sequencing and long-read sequencing and illustrated their
advantages and drawbacks. In chapter 2, I summarized the major haplotyperesolved DNA sequencing approaches, which include Hi-C, synthetic long reads
and CPT-Seq. In chapter 3, I provided a detailed description of our novel methods
to construct NGS library directly on a solid surface, which simplified NGS pipeline
significantly and can contribute to the goal of sequencing a genome for $100. In
chapter 4, an approach to generate megabase long linked reads is described. With
DNA combing, surface tagmentation and barcode-enabled DNA chip, the method
would allow us to assemble and phase the variants across entire chromosomes.
In the last chapter, I discussed the potential application of our technologies in
epigenomics, RNA sequencing and genomic medicine. The technologies
described in this dissertation will transform genomics and have impacts in the
biological sciences, from personalized medicine to de novo sequencing of human
genome.
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Chapter 1
Introduction --- DNA Sequencing Technology

1.1 A brief history of DNA sequencing technology
First generation of DNA sequencing, which is also called Sanger Sequencing, was
developed by Frederick Sanger and his colleagues in 1977 (1). They used chain
termination method with dideoxynucleosides to obtain the sequence of DNA. At
about the same period of time, Maxam and Gilbert introduced another approach
to sequence DNA with digestion reactions that preferentially cleave at guanines,
adenines, cytosines or thymines (2). These two DNA sequencing methods made
it possible to decipher our genomes and thoroughly transformed biomedical
research. As a result, they shared the1980 Nobel Prize in Chemistry. In 1990, the
Human Genome Project (HGP) was launched to determine the sequence of DNA
that make up the human genome using Sanger sequencing. The project was
completed in 2003 with the collaboration of researchers from United States, United
Kingdom, France, Australia and China (3).

Sanger sequencing is accurate but the throughput is relatively low, which lead to
laborious work and high cost when sequencing large genome. It cost $3 billion and
15 years to complete HGP, which is very inefficient. Therefore, people started
looking for new technologies to elucidate DNA sequence. In 2005, 454 Life
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Sciences (acquired by Roche) released pyrosequencing (4), which marked the
beginning of the Next-Generation Sequencing (NGS) era. Pyrosequencing
significantly improved the throughput by sequencing multiple DNA molecules
simultaneously. In contrast to the sequencing by synthesis (SBS) method, the
detection of nucleotide incorporation is real time, which gets rid of laborious gel
running process and streamlines the whole procedure. One year later, Solexa
(acquired by Illumina) sequencer was commercialized, which made use of
reversible terminators during sequence detection (5). The Illumina sequencer
increased throughput by generating much more reads than 454 system (100
million vs 200,000). In 2010, Personal Genome Machine (PGM) was released by
Ion Torrent (acquired by ThermoFisher) and this system resembles the 454
platform as for the principle of sequencing (6). Rather than using optical system to
detect the release of pyrophosphate, PGM is based on semiconductor technology
and uses ion sensors to detect the release of protons, which results in a smaller
sequencing instrument with improved sequencing efficiency. In 2007, Applied
Biosystems (acquired by ThermoFisher) developed a sequencer based on
sequencing by ligation (SBL) technology and it was named as Sequencing by Oligo
Ligation Detection (SOLiD), which used a mixture of color labelled oligonucleotides
(7). Once they hybridized to the single strand DNA (ssDNA), the complimentary
sequence can be determined based on the known sequence of fluorescent
oligonucleotides. Since the data processing is sophisticated, it is rare to see people
using this method today.
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Currently, Illumina sequencers dominate the sequencing market after years of
research and development. With the highest throughput per run and lowest perbase cost (8), Illumina sequencing technology has greatly improved the
development of both basic and clinical research. The cost of DNA sequencing
dropped dramatically during the last decade and the goal of sequencing a human
genome for less than $1000 was achieved several years ago. With the most recent
sequencer from Illumina, which is called NovaSeq, the cost will be less than $100
in the near future. Recently, Single Molecule Real Time sequencing (SMRT)
developed by Pacific Biosciences (PacBio) is more and more popular and has
been widely used for genome research (9). And Oxford Nanopore Technology
(ONT) also released several sequencing platforms based on its nanopore
technology (10,11). Both technologies allow long read (> 10 kb) sequencing and
do not require PCR amplification, which is a big improvement compared to NGS
technologies. In the following part, Illumina Sequencing, PacBio Sequencing and
Nanopore Sequencing will be discussed in detail.

1.2 Current DNA sequencing technologies

1.2.1 Illumina Sequencing
Overview
Illumina sequencing is based on SBS technology, which is the most widely used
approach for DNA sequencing. Generally, a universal primer anneals to the single
strand DNA (ssDNA) template and extends with polymerase. Every incorporation
3

of a new oligonucleotide will create a signal, which can be captured by a sequencer.
Therefore, the sequence of DNA can be determined. In addition, Illumina
developed a novel approach to amplify template DNA, which is called bridge PCR
(5). Sequencing clusters are formed on solid surface through this method and each
cluster is a collection of clone duplicates of one unique DNA molecule. The clusters
are used for enlarging fluorescent signal and reducing noise signal. The whole
process of Illumina sequencing consists of 3 steps: library preparation, cluster
generation and sequencing.

Library preparation
There are 3 steps for a conventional NGS library preparation protocol for DNA:
fragmentation, adaptor ligation and PCR amplification. To start, the genomic DNA
is fragmented mechanically (e.g. sonication) or enzymatically (restriction enzyme
digestion). People tend to use sonication because enzymes usually shear DNA at
their preferable cutting sites, which can generate digestion bias. Then, the
fragmented DNA molecules are polished to blunt ends, “A” tailed and a pair of
forked oligonucleotides is added to both ends of DNA fragments through A-T
ligation. Finally, the DNA fragments are amplified by PCR with universal primers
to add sequencer specific primers as well as obtain enough material for
sequencing. Most of the commercial NGS library preparation kits follow this
standard procedure and it takes around 10 hours to construct a library. Epicentre
(acquired by Illumina at 2011) developed a special kit called Nextera, which greatly
simplifies the whole process by using transposases (12). The engineered
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transposase can break DNA and insert short oligonucleotides at nearly random
position (13). Therefore, when the transposases are coupled with sequencer
compatible sequences (or adaptors), they can fragment DNA and ligate adaptors
(or tagging) at both ends simultaneously. So, the process is named as
tagmentation. With Nextera kits, a library can be prepared within 2 hours. Also,
there are library preparation kits that do not require final amplification, which
generate libraries of high quality by avoiding PCR duplicates and bias.

Cluster generation
After library preparation, DNA molecules are loaded onto a solid surface (flow cell)
for cluster generation (Figure 1). The library molecules are first denatured so that
ssDNAs can anneal to the oligonucleotides on flow cell through their
complementary parts (flow cell or FC1/2). Then, the oligonucleotides on surface
serve as primers and extend with a polymerase to form a new complimentary
strand. Afterwards, the original ssDNAs are removed by denaturation and the
newly synthesized strand bend over to anneal to the surface bound
complementary oligonucleotide, results in bridge structures. Again, the extension
from the 3’ end of the oligonucleotide on flow cell will form another new strand. By
repeating the cycles of annealing, extension and denaturation, numerous identical
ssDNAs will be generated to form a cluster, the physical diameter of each cluster
is ~ 1 µm (14).
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Figure 1. Illumina bridge PCR for cluster generation.
(a) Randomly fragment genomic DNA and ligate adapters to both ends of the
fragments. (b) Bind single-stranded fragments randomly to the inside surface of
the flow cell channels. (c) Add unlabeled nucleotides and enzyme to initiate solidphase bridge amplification. (d) The enzyme incorporates nucleotides to build
double-stranded bridges on the solid-phase substrate. (e) Denaturation leaves
single-stranded templates anchored to the substrate. (f) Several million dense
clusters of double-stranded DNA are generated in each channel of the flow cell.
(adapted from www.illumina.com)
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Sequencing
Illumina sequencing technology is based on SBS, which makes use of reversible
terminators so that only one base can be incorporated in a cycle. The 4 reversible
terminators (3’-O-azidomethyl 2’-deoxynucleoside triphosphates) are coupled with
a different removable fluorophore, once incorporated during sequencing, a picture
will be taken to determine the identity of the base by the intensity of laser-induced
excitation of the fluorophores (5). The terminators prevent the incorporation of new
bases so that all four bases can be added simultaneously rather than sequentially,
which not only solves the homopolymer issue, but also decrease the possibility of
mis-incorporation. After the signals are captured, the fluorophores are cleaved by
tris(2-carboxyethyl)phosphine (TCEP) so that they will not affect the following
cycles. TCEP can also remove the side chain and add 3' hydroxyl group to allow
the incorporation of new bases in the next cycle. With cycles of incorporation,
imaging, cleaving, the DNA sequence can be determined. The MiSeq Sequencer
from Illumina can run up to 300 cycles, which means they can sequence 300 bp in
each direction and after which the data quality drops dramatically.

Illumina Sequencers
With years of research and development, Illumina has introduced a broad range
of sequencing platforms to the market for different applications. In the early 2017,
Illumina introduced NovaSeq, which produces up to 20 billion reads per run within
two days. With such a powerful sequencer, $100 genome goal will be reached
soon. In the early 2018, Illumina brought iSeq to the market, which is a desktop-
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size sequencer and costs less than $20,000. iSeq can generate 4 million reads in
less than 18 hours, which is enough for the daily use of most labs. There are also
other platforms (e.g. MiSeq, NextSeq and HiSeq) that have been used in almost
all areas of genome science research. They can produce considerable amount of
data with reasonable cost.

The biggest drawback of Illumina sequencing technology is the short length of
sequencing reads, which is less than 300 bp in a single direction. The short reads
can cause troubles for the downstream data analysis (e.g. haplotyping, structural
variation detection) and limit its application for large genome (e.g. human) studies
(15,16). Therefore, people have been trying to develop new approaches that could
generate longer reads which results in two new technologies, PacBio Sequencing
and Oxford Nanopore Technology. They are also called the Third-Generation
Sequencing (TGS).

1.2.2 PacBio Sequencing and Oxford Nanopore Technology
PacBio Sequencing
Sigle-molecule, real-time DNA sequencing (SMRT) was first developed by Pacific
Biosciences (9). The library preparation is very minimal, and no PCR amplification
is needed for this technology. Besides, the DNA template is sequenced as a single
molecule rather than a cluster. PacBio sequencers also use sequencing-bysynthesis strategy but the average read length can be as long as 200 kb (9).
8

Prior to sequencing, hairpin adaptors are ligated to both ends of a double-stranded
DNA (dsDNA) template to form a closed, single-stranded circular DNA (sscDNA),
which is also called SMRTbell. Once a SMRTbell enters a sequencing well, it can
be captured by the phi29 polymerase that anchored at the bottom of the well. Then
the sequencing starts, every time a new dNTP is incorporated, the fluorescent on
it can be detected and after a certain amount of time, the fluorophore group is
cleaved before the incorporation of the next nucleotide. In this way, a light pulse is
recorded by the sequencer. Since the cleavage time of different dNTP is
distinguishable, the identity of each incorporated base can be determined. To
avoid detecting the signal comes from other floating fluorescent dNTP in the same
well, the sequencer made use of a special nanophotonic structure, which is called
the zero-mode waveguide (ZMW). With ZMW, the volume of observation is very
minimal and only fluorescent on the dNTP that held by the polymerase can be
detected (17). The phi29 polymerase is selected because of its high accuracy and
extension speed. With several site-specific mutations, the engineered phi29 can
incorporate fluorescent dNTP at very high efficiency (18,19).

There are two major PacBio sequencing platforms: PacBio RSII and Sequel. The
PacBio RSII can produce up to 1 Gb per run in 4 hours and the Sequel can produce
up to 10 Gb per run with the same amount of time (20). Despite the low throughput
of PacBio Sequencing, long read is a big advantage over Illumina sequencing
technology. The average read length of PacBio sequencer is around 20 kb and the
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longest can be over 200 kb (21-23). With such long reads, de novo assembly for
large genomes would be possible, particularly for resolving the repetitive regions,
which, however, remains challenging for short-read approaches (e.g. Illumina
sequencing). Unlike NGS technologies, PCR amplification is not required for
PacBio sequencing library construction, which avoids duplicates and bias.

Figure 2. Principle of single-molecule, real-time DNA sequencing.
(A) Experimental geometry. A single molecule of DNA template is fixed at the
bottom of a ZMW by an immobilized phi29 DNA polymerase. The ZMW
nanostructure provides excitation confinement in the zeptoliter (10 −21 liter) regime,
enabling detection of single phospho-linked nucleotide substrates against the bulk
solution background when they are incorporated into the DNA strand during
polymerase extension. (B) Schematic event sequence of the phospho-linked dNTP
incorporation cycle, with a corresponding expected time trace of detected
fluorescence intensity from the ZMW. (1) A phospho-linked nucleotide forms a
cognate association with the template in the polymerase active site, (2) resulting
an elevation of the fluorescence output on the corresponding color channel. (3)
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Phosphodiester bond formation releases the dye-linker-pyrophosphate product,
which diffuses out of the ZMW, thus generating the fluorescence pulse. (4) The
polymerase translocates to the next position, and (5) the next cognate nucleotide
binds to the active site which initiates the subsequent pulse (9).

Oxford Nanopore Technology (ONT)
The idea of Nanopore Sequencing was first raised in 1980s (11), but it was not
until 2014 that the first nanopore sequencer was released (10). The two major
technical difficulties for developing nanopore sequencing is the choice of a protein
to serve as pore and control the speed of DNA translocation within the pore (24).
After years of research, an engineered MspA protein was chosen because of its
perfect size, ~ 1.2 nm wide and ~ 0.6 nm long (25), so that the ionic current through
the pore is only affected by a minimal amount of DNA bases, which eventually
would allow single base detection. To control the speed of DNA translocation,
phi29 polymerase is used for its extension and exonuclease activities to move DNA
in single base steps (26,27). Also, phi29 polymerase is relatively stable and
generate very long DNA molecules with a single strand template (28,29), which
allows long read sequencing for nanopore technology.

For Nanopore Sequencing, a small pore is imbedded in a membrane, which allows
the flow of ionic current when a voltage is added to both sides of the membrane.
When a strand of DNA passes through the pore, it generates the changes in the
current that can be recorded by a detector. The change of current is different based
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on which nucleic acid base is passing through the pore. In this way, the sequence
of DNA can be determined. As epigenetic modified bases create their own unique
current changes while passing through the nanopore, they can be detected directly
during the sequencing process, though at lower accuracy than PacBio.

There are three Nanopore Sequencing platforms: MinION, GridION and
PromethION. In 2014, ONT introduced its first sequencer--- MinION. MinION is a
mobile phone size portable device, which makes it a perfect instrument for
sequencing in the field. With only one flow cell build in, MinION can generate up
to 20 Gb of sequencing data in less than two days. One year later, ONT brought
PromethION into the market, which was a great improvement on sequencing
throughput. PromethION can hold up to 48 flow cells and produce up to 6 Tb data
around two days. In early 2017, another sequencer was released, which is called
GridION, GridION can hold five flow cells and generate up to 100 Gb data per run.

Oxford Nanopore Technology (ONT) has several advantages: First, no PCR is
needed and very minimal library preparation is required prior to sequencing (20).
With its rapid sequencing kit, a library is ready for sequencing with less than 10
min preparation. Second, ONT can produce very long sequencing reads and the
longest read that has been reported is 2,272,580 bases (30). With such long reads,
the DNA sequences in most of the repetitive regions for human genome can be
easily resolved. Third, ONT enables direct detection of epigenetic modifications in
DNA, which significantly improves the efficiency of genome research.

12

Figure 3. Nanopore sequencing.
(a) Two ionic solution-filled chambers are divided by a voltage-biased membrane.
A single-stranded polynucleotide (black) is electronically driven through an MspA
nanopore (green) that provides the only path through which ions or polynucleotides
can move from one side (the cis) to the other side (the trans) of the chamber.
Translocation of the polynucleotide through the nanopore is controlled by an
enzyme (red). (b) Portion of a record showing the ionic current through a nanopore
measured by a sensitive ammeter. In nanopore strand-sequencing, the stepping
rate is usually 30 bases per second, but this experiment was carried out using
exceptionally low concentrations of ATP to slow the helicase activity, thereby
increasing the duration of each level to illustrate the resolution that can be
achieved (11).

13

1.3 Summary
DNA sequencing technologies have undergone unprecedent development during
the last 40 years. And the sequencing market is dominated by Next-generation
sequencing technologies (NGS) for their low per base cost and high throughput.
With NGS, it only costs several hundred dollars to sequence a human genome
within a day while $3 billion and 15 years were used to complete the Human
Genome Project (HGP) by Sanger sequencing. The tremendous efficiency of NGS
is based on massive parallel sequencing, which means hundreds of millions of
DNA fragments are sequenced at the same time. With the low per base cost and
high throughput, NGS sequencers are more and more popular and it is widely used
for basic research to study the genome of a broad range of organisms. Together
with the current available bioinformatics tools, numerous genomes have been
assembled, which made a great contribution to the biology research. Unlike
microarray technique, which only allow to analyze a few specific genes in the
genome, NGS technologies enable whole genome analysis with single base
resolution. Besides, NGS has been applied to clinical diagnosis. For example, it is
very common to use NGS for the detection of deleterious mutations which related
to certain disease for newborns and cancer patients (31-36).

Though NGS technologies are powerful and widely used, there are several
shortcomings. The biggest problem is that sequencing reads are too short
compared to the length of large genomes. The long repetitive regions in human
genome are challenging for NGS, which results in mis-assemblies and gaps.
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Because of this, the current human reference genome is still incomplete and the
haplotype information is largely missing (37,38). In addition, many complex
structural variations (SV) cannot be detected by NGS while they are always
associated with many diseases (e.g. cancer).

Figure 4. Comparison of the performance of short-read and long-read
methods.
(A) Example showing the assembly of a repetitive region by short reads or long
reads. Sequencing a region with two nearly identical repeats (blue) separated by
15

a unique sequence will generate reads corresponding to the upstream region
(yellow), the repeats, the sequence between (green), and the downstream region
(black), and some reads will overlap the boundaries. De novo assembling tools
cannot assign reads falling in the repeats to unique positions and will assemble
those reads into a single contig. The sequence between the repeats cannot be
assigned to a unique position either as it can be placed either upstream or
downstream of the ‘blue’ region. Due to this ambiguity, the sequences upstream
of, between, and downstream of the repeats will be assembled into separate
contigs. Similar problems arise with structural variants that involve repetitive
regions. (B) Haplotype phasing. SNPs (single nucleotide: A or C) or larger
variations (red or blue) between maternal and paternal alleles located too far apart
to be covered by a single read will be difficult to phase to the corresponding
parental allele. This will lead to ambiguous trajectories that result in fragmented
assemblies. (C) A multitude of mRNA transcript isoforms can be generated from a
single gene through alternative splicing. Short-read sequencing of those isoforms
will produce reads falling within the exons present in the pool (unbroken lines) and
there will be reads that overlap the various exon junctions (broken lines). Thus, the
alternative splicing events will be detected; the exon–exon junctions detected in
the pool are indicated by red lines. However, information about the combination of
exon junctions in the individual transcripts is missing. Long-read sequencing
covers the entire transcript and will thus provide this additional information. (D)
NGS methods depend on PCR amplification during library preparation and/or on
the flow cells. PCR is a bias-prone process that tends to be inefficient at extreme
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GC content. As a result, regions with extreme GC content will often be poorly
covered. PacBio sequencing and Oxford nanopore long-read sequencing
technologies do not require PCR amplification and suffer much less of this problem
(20).

The read length of NGS is limited mostly by the chemical reaction efficiency. After
several hundred cycles of sequencing, the mis-incorporation of fluorescent dNTP
is more frequent, which makes it difficult for base calling and data quality drops
dramatically. Therefore, only several hundred bases are of high accuracy. PacBio
use different strategies to sequence DNA, which not only allow single molecule
real time sequencing but also extend the read length to 20 kb. Long-read
technology has great advantage over short-read method on resolving repetitive
sequences and capturing complex structural variation. A recent study shows that
most of the structural variations (SVs) called by NGS are false positives. In addition,
based on statistical calculation, 10x coverage is enough to capture all SVs
breakpoints when using 10 kb reads while 25x coverage is needed for 2x 100 bp
short reads (39). This indicates that long reads are more efficient for SV analysis.
ONT produced even longer reads than PacBio Sequencing. With the ultra-long
reads (~800 kb), ONT successfully closed twelve 50 kb long gaps in the human
reference genome (40). Besides, by integration of 48 flow cells in one device, ONT
sequencer reaches same level of throughput as Illumina’s HiSeq X. Another
advantage of these TGS technologies is that they can detect epigenetic
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modification directly because the modified bases generate different signals
compared to regular bases (41-43). Though PacBio Sequencing and ONT
technologies can produce long reads, they both have a drawback, high error rate.
For PacBio Sequencing, the error rate is 13% (44). And it’s 15% for ONT (45). With
such high error rate, the original read cannot be used directly for genome assembly
unless it is fixed by some computational algorithm or accurate short reads.

Due to the problems discussed above, people choose to sequence their samples
with both NGS and TGS. By using single molecule real time (SMRT) sequencing
and Illumina Sequencing together with DNA mapping technologies, a group
generated the most complete Korean genome assembly with a scaffold N50 size
of 44.8 Mb and phased the genome that covers 89% of genes (46). People also
developed a hybrid approach to obtain high quality long reads. With PBcR (47), a
bioinformatics software, the errors in PacBio reads can be fixed by short reads
from Illumina sequencing platform, which improve the accuracy of long reads to
99.9%.
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Chapter 2

Complete Genome --- Whole Genome Haplotyping

2.1 Introduction
A complete human genome sequence with diploid features derived from both
parental chromosomes represents the ideal reference for comprehensive
understanding of human genetic variation. Diploid assemblies provide detailed
information about the contiguity of haplotype segments with assigned phased
alleles that include single nucleotide variants (SNVs), short insertions and
deletions (indels), structural variations (SVs), and genomic regions with complex
structures (48-50). A comprehensive understanding of human biology and disease
requires having the complete genetic code that governs every cell in our body, also
called a genome reference (51,52). The current genome reference lacks many
features and thus, does not fully describe the content of the human genetic code
(22,53,54).

As I discussed in the last chapter, it is very difficult to gather long-range (several
hundred kilobases) information, like long phased block, whole genome assembly
and structure variation with the current short-read technologies. In the human
genome, even with the long-read approaches there are still gaps and unresolved
sequences because the reads are not long enough, have a high error rate and low
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throughput (55). Therefore, novel technologies are needed to elucidate the missing
information in the human genome.

To phase the human genome and acquire a comprehensive understanding of the
genome, several approaches have been developed, which include dilution
haplotyping (56,57), Hi-C (58), synthetic long read sequencing (59-62) and CPTSeq (63). All these methods used sophisticated approaches to prepare the
sequencing libraries in order to reserve more information from the original genome.
The principle of dilution haplotyping is to dilute starting material so that there is
only one sub-haploid genome equivalent. And prepare libraries with each portion
in parallel. When these libraries are sequenced, the haplotype information can be
obtained. With Hi-C, all the chromosome interactions can be captured by crosslinking and proximity ligation. As most of the captured interactions are within the
same chromosome, the haplotype can be generated accordingly. For synthetic
long read sequencing and CPT-Seq, they both use barcode labelling technique.
With their unique barcode system, the genome is marked, and every piece is
trackable. Therefore, it is more likely to get unique alignment and acquire more
genome information rather than struggle with short read that has multiple hits. In
this chapter, I will describe Hi-C, synthetic long read sequencing and CPT-Seq
technologies in detail.
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2.2 Hi-C
Chromosome conformation capture (3C) is a technique to study long-range
interactions between specific pairs of loci, which used proximity ligation and locusspecific amplification (64). For 3C, only specific targets can be analyzed every time
and it is impossible for whole genome long-range interactions analysis. Dr.
Dekker’s group modified the 3C protocol and developed a novel method called HiC, which allows unbiased study of chromosome interaction in whole genome (65).
Hi-C starts with cell crosslinking, where all the chromatin interactions are fixed by
formaldehyde. Then DNA is digested overnight with a restriction enzyme which
generates sticky end. Biotinylated dCTPs are used to fill the end followed by
proximity ligation. Finally, DNA is sheared and the biotin labelled fragments are
selected for sequencing (Figure 5).

Hi-C can capture all the chromosome interactions within the genome, which
include both intra-chromosome (cis) interaction and inter-chromosome (trans)
interaction. The data from Ren’s group showed that the vast majority of Hi-C reads
are from cis interactions while less than 2% of the captured interactions are trans
interaction (66). In addition, they found that the reads are more likely to originate
from trans interaction as the insert size increase. When the insert size is limited to
less than 30 Mb, the overall trans interaction is less than 0.6%. Based on this fact,
they used Hi-C data to generate high quality haplotypes, which covered 81% of
the alleles with 98% accuracy at the sequencing depth of 17x.
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Even though the Hi-C technique has been shown to capture long-range information
and phase the genome. It has several drawbacks that prevent it being widely used
to explore whole genome information. First, a lot of starting material is needed.
Normally, Hi-C starts with 5x106 cells (~ 30 µg DNA). It would be challenging when
the cells are limited, particularly for patient sample. Second, the protocol to prepare
Hi-C library is laborious. It is not economical when considering the cost of time and
experimental materials. Finally, Hi-C cannot generate complete genome
information as only the area near chromosome interactions can be sequenced.

Figure 5. Overview of Hi-C.
Cells are cross-linked with formaldehyde, which generates covalent links between
spatially adjacent chromatin segments (DNA fragments shown in dark blue, red;
proteins, which can mediate such interactions, are shown in light blue and cyan).
Chromatin is then digested with a restriction enzyme (here, HindIII; restriction site
marked by dashed line; see inset), and the resulting sticky ends are filled in with
nucleotides, one of which is biotinylated (purple dot). Ligation is performed under
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extremely dilute conditions to create chimeric molecules; the HindIII site is lost and
an NheI site is created (inset). DNA is purified and fragmented. Biotinylated
fragments are isolated with streptavidin beads and identified by paired-end
sequencing (65).

2.3 Synthetic Long Reads Sequencing
The current sequencing technology is extremely powerful compared to Sanger
sequencing, high throughput with very low per base cost. However, the relatively
short reads limit our exploration of the human genome, leaving many problems to
be solved. The third-generation sequencing produces much long reads and
provides us a more complete view of the human genome. But the high error rate
and per base cost prevent it being widely used for human genome studies.
Recently, synthetic long reads (SLR) sequencing was developed to take
advantage of both short-reads and long-reads technologies (67,68). SLR
generates very long reads from Illumina sequencing platform, so the reads are of
high accuracy and the per base cost is relatively low. SLR sequencing starts with
partitioning long DNA fragments (10 kb ~ 100 kb). This step is very similar to
dilution haplotyping and each partition only contains few DNA molecules. Then
DNA in each partition is fragmented and ligated to unique barcode. After standard
Illumina sequencing, the short reads can be assembled into long DNA fragments
according to their barcodes because all the reads come from the same DNA
partition (or DNA fragment) share the same barcode. There are two major SLR
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technologies, one is from Illumina and the other is from 10X Genomics. Both will
be reviewed in the following parts.

2.3.1 Illumina’s Synthetic Long Reads Technology
In 2014, Illumina introduced its SLR library preparation kit (formerly Moleculo). This
method can generate synthetic reads as long as 10 kb, which is comparable to the
length of PacBio reads but the accuracy is much better than the long-reads
technology. Generally, the whole genomic DNA is sheared to large fragments (6
kb ~ 8 kb). These large DNA fragments are then diluted into 96-well plates so that
each well contains around 500 DNA molecules. In each well, the library is prepared
with standard NGS library preparation protocol: fragmentation, end repair, adaptor
ligation (unique barcode included) and PCR. Finally, pool the libraries from all wells
and sequence on an Illumina sequencer. The synthetic reads are generated based
on the linked barcode as the reads contain same barcode are more likely to be
originated from the same large DNA fragment. It is notable that limiting the number
of DNA fragments in a well can greatly increase the synthetic reads accuracy. Also,
more wells are needed for large genome assembly. For example, twelve 96-well
plates were used for library preparation with human genomic DNA.
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Figure 6. Illumina’s synthetic long reads technology.
Genomic DNA is sheared into 6–8 kb fragments, partitioned into twelve 96-well
plates, further fragmented to 600–800 bp, barcoded and sequenced separately for
each well (67).
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2.3.2 10X Genomics
One year after Illumina introduced its synthetic long reads technology. 10X
Genomics developed a microfluidic based method which produced much longer
synthetic long reads (68). This approach starts with 1ng of high-molecular weight
(HMW) genomic DNA. With its microfluidic platform, DNA molecules are distributed
into around 100,000 droplet partitions, which contain oligonucleotides (barcode)
functionalized gel bead and reagents mixture. Then the barcodes are added to the
DNA followed by random amplification. After that, the barcode labelled DNA
molecules are released from the droplet and undergo standard Illumina short-read
sequencing. Finally, the short reads are linked together and assembled into long
reads based on their barcodes. Since only 1 ng (equals to 300 genomic
equivalents) of genomic DNA is used and there are more than 100,000 partitions,
only a small number of genomic equivalents are labeled with same barcode. And
it has been shown that it’s nearly impossible for two different DNA molecules which
cover the same position on the genome but have opposing haplotypes will share
a barcode (68).

10X Genomics’ synthetic long read technology is better than Illumina’s because it
requires much less starting material, only 1 ng of DNA is needed while 500 ng of
DNA is required for Illumina’s SLR method. In addition, 10X Genomics’ GemCode
instrument can generate 1 million partitions while there are only 384 partitions for
Illumina’s SLR technology. More partitions make it easier to assemble the short
reads and require less depth of sequencing. Another advantage over Illumina’s

26

SLR technique is that 10X Genomics starts with much longer fragments (100 kb
vs 10 kb), which ends with longer synthetic reads after sequencing. However, to
make use of 10X Genomics’ technology, a GemCode instrument (~$125,000) is
required for sample partitioning, which adds extra cost to the total expense for
sequencing.

Synthetic long read technologies provide us a better solution for short-read
problem than the long-read methods (PacBio, ONT). The length of synthetic read
is comparable to PacBio’s read (~50 kb), but the reads accuracy is higher and the
per base cost is much lower. With synthetic long reads ranging from 50 kb to 100
kb, repetitive elements and complex structure variations as well as haplotypes can
be resolved easily. However, for both synthetic long read technologies, PCR
amplification is required during library preparation, which introduces bias and
errors to the final library. The bias may lead to low coverage in the high or low GC
regions and the errors may cause mis-alignment (69-71). In addition, the length of
synthetic read is still limited to several hundreds of kilobases, which is not long
enough to span the repetitive regions in the human genome or to reveal complex
structure variation that are several megabase long (72,73).
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Figure 7. Synthetic long reads technology from 10X Genomics.
Gel beads loaded with primers and barcoded oligonucleotides are mixed with DNA
and enzyme mixture then oil-surfactant solution at a microfluidic ‘double-cross’
junction. Gel bead–containing droplets flow to a reservoir where gel beads are
dissolved, initiating whole-genome primer extension. The products are pooled from
each droplet. The final library is prepared by fragmentation, end-repair, Illumina
adapters ligation and PCR amplification (68).

2.4 CPT-Seq
Recently, Illumina developed another barcode labeling system (63), which allows
haplotype-resolved genome sequencing or contiguity-preserving transposition
sequencing (CPT-Seq). CPT-Seq makes use of Tn5 transposases (12,13), which
fragment DNA and add sequencing adaptors at the same time (tagmentation).
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More importantly, once Tn5 transposases insert the adaptor sequence into
genomic DNA, they are still attached to the binding sites and hold all the DNA
fragments in one piece until striped off with SDS. Therefore, Tn5 transposases can
be used as an excellent tool to label very long genomic DNA without shearing it.
With its unique two-step indexing scheme, the first index (M = 96) is incorporated
into the genomic DNA library during tagmentation, and the second index (N = 96)
is added during the final library PCR process. In this way, the genomic DNA is
partitioned into 9,216 (M x N = 96 x 96 = 9,216) compartments, Also, the same as
10X Genomics’ approach, 1 ng of genomic DNA is used to start with. Therefore,
there is only 3% haploid content per compartment and the haplotypes can be
acquired after sequencing and demultiplexing using a simple computational
algorithm.
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Figure 8. Overview of the CPT-Seq workflow.
There are three key steps: (I) indexed tagmentation, (II) pooling, dilution and
compartmentalization, and (III) indexed PCR. A set of 96 different indexed
transposase complexes are used to set up 96 independent tagmentation reactions
to generate separate virtual genomic partitions (step I). Tagmentation reactions
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are pooled together, diluted to sub-haploid DNA content and split into 96
compartments (step II). Upon removal of the transposases with SDS,
compartment-specific libraries are generated using indexed PCR (step III). All
samples are pooled together after PCR and got ready for sequencing (63).

Two years later (In year of 2017), Illumina introduced the second version of
contiguity preserving transposition sequencing (CPTv2-Seq), which used
tagmentation on solid surface (74). There is a commercial kit available based on
this method (Nextera DNA Flex Library Prep Kit). First, Tn5 transposases with
unique barcode are fix on beads. Then genomic DNA is captured by the
transposase and library is prepared after several enzymatic reactions:
tagmentation, extension-ligation and PCR amplification. It is shown that only one
long DNA molecule is captured by one bead so that all the library fragments from
one bead would have the same barcode. There are 147,456 (384 x 384) distinct
indexed transposome beads, which partition the genomic DNA into more
compartments then CPT-Seq. Therefore, the performance is much better and less
depth of coverage for sequencing is needed as we discussed in the last part of this
chapter. At the sequencing depth of 20x, they phased 99.5% of the heterozygous
SNPs (hetSNPs) with only 1 error in 100 Mb. Also, the phasing block N50 was 2.43
Mb with the longest up to 5.48 Mb (74).
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Illumina’s CPTv2-Seq method improved the overall performance of haplotyping by
generating much more partitions than SLR technologies. With Tn5 transposases,
genomic DNA labeling and library preparation are merged into one step, which not
only simplify the process but also save a lot of starting material. More importantly,
no expensive microfluidic instrument is needed for partitioning and barcode
labeling. However, the length of DNA molecule that captured by one bead is still
limited to several hundred kilobases due to the size of bead (3 µm) and preparation
of the genomic DNA (shearing and fragmentation) before loading to the beads is
still needed.

Figure 9. CPTv2-Seq workflow.
(a) Overview of on-beads tagmentation and indexing. Tagmentation on beads in a
single tube is followed by PCR (single-tube method), or a 384-well barcoded PCR
(hybrid

method). Close-up

visualization shows

clonally barcoded

bead

transposition with ‘virtual compartments’ inside a single physical compartment.
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The hybrid approach starts with the preparation of 96 uniquely indexed,
biotinylated transposase complexes that were individually loaded on streptavidin
beads and combined to make a bead pool used for tagmentation. After
tagmentation, the beads were distributed into 384 wells for a second round of
indexing by PCR. In the single-tube method, the bead pool with ~150 K distinct
barcodes

which

were

synthesized

using

a

split-and-combine

strategy.

Transposomes loaded with a universal transposon were hybridized via its common
hybrid′ (Hyb′) sequence to the hybrid (Hyb) sequence attached to the barcoded
beads. A long DNA molecule in proximity to a single bead is tagmented multiple
times by transposomes on that bead, generating individual libraries with the same
barcode. (b) Results of initial feasibility experiment with two bead types, barcode
1+2 and barcode 3+4 demonstrating that target DNA is clonally barcoded through
transposition on a single bead. (c) Combinatorial transposome bead pool
preparation used for single-tube approach (for simplicity, only one bead type and
a half of the dimer transposome complex are illustrated). A split-and-combine
synthesis strategy was used to make a ~150 K (384 × 384) bead pool, with each
bead holding a unique index combination. Initially, 384 uniquely indexed beads
were individually prepared with barcode 1 sequences (yellow box). The beads
were pooled and split into a new 384-well plate for splint-assisted ligation (reddash arrows) with a set of 5′ phosphorylated oligos, containing a unique barcode
2 sequence (green box). The transposase complexes, formed with a universal
transposon, were hybridized to a common hyb sequence (purple box) on the beads,
generating the 150 K barcoded tagmentation-active bead pool. (d) Workflow for
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library generation. The 150 K barcoded tagmentation-active bead pool was
prepared as described above (only halves of transposome dimers are illustrated).
Long DNA molecules were mixed with the bead pool and tagmented by
transposomes on the bead surface. After tagmentation, Tn5 transposase was
released by SDS to allow the extension/ligation steps to fill the gaps (9-bp gap
from transposition) and ligating the bead index oligo to the library. Finally, the
sequencing adapters were introduced by PCR amplification (74).

2.5 Summary
The Human genome is diploid meaning there are two sets of chromosomes in each
cell, one comes from mother and the other comes from father. Currently, it is still
challenging to determine which chromosome it comes from when a genetic
variation is detected with current sequencing technology. However, the location of
a specific mutation may have strong impact on gene regulation and is often related
to certain disease. The phased information is not only critical to human leukocyte
antigen typing (75), but also plays an important role in medical genetics, population
genetics (76-78) and cancer genetics (48). Generally, there are two approaches
for whole genome haplotyping, computational approach and experimental
approach. For computational phasing, certain amount of population level
sequencing data as well as complicated algorithm are needed. And the variants
with low frequency in the population may not be correctly phased (79-81). The
experimental methods often include extensive sequencing and complicated library
34

preparation. For example, to acquire phased information by Hi-C sequencing,
more than a week is needed to prepare the sequencing library and a large number
of starting material (5x106 cells) is needed.

The current sequencing technology fails to generate phased genome information
because the reads are too short (<300 bp) and only one or two variants are
contained in a single read (82-84). Therefore, it is very difficult to link the variants
that come from the same chromosome. To increase the read length is the most
straightforward way to solve this problem. However, the long-read technologies
often suffer from low throughput, high cost and low accuracy. Alternatives would
be SLR technology, which generate long reads by using short-read sequencing.
As reviewed in this chapter, Illumina and 10X Genomics use dilution or microfluidic
partition to get sub-haplotypes and label them with barcode, then create phased
genome with their corresponding computation algorithms. Normally, the more
partitions they create, the better phasing performance they can achieve. 10X
Genomic SLR technology generates much longer haplotype blocks than Illumina’s
but they require extra expensive instrument (GemCode). Then, Illumina developed
CPT-Seq, which is based on a tagmentation labeling system and further improved
the length of phased blocks and simplified the protocol as well.
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Consider all the problems and challenges described in previous chapters, our goal
is to develop a novel method to provide a more complete human genome
sequence and allow genome studies to accurately identify all variants and phase
them to the appropriate homologous chromosome. Ultimately, our approach would
decrease the cost of whole genome sequencing while dramatically increase the
accuracy and completeness of the results.

The basic approach is to stretch multiple megabase (Mb) long DNA molecules on
a barcoded chip surface (30-40x diploid genome coverage). Then fragment the
DNA molecules and ligate them to the DNA chip, which serve as templates for
traditional NGS libraries (Figure 10). Finally, the library is sequenced on an Illumina
sequencer. Since the oligonucleotides on chip contain barcodes (22-26 bp), which
indicate their physical location on chip surface, we can obtain a scaffold for
assembling the short NGS reads. Scaffolding the short reads will allow for high
quality de novo assembly, and very accurate single nucleotide variant detection,
structure variant detection, and phasing haplotypes from diploid samples.
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Figure 10. Megabase Sequencing.
Megabase long dsDNA (marked in green) are stretched on a DNA chip. The DNA
molecules are then fragmented and ligated to oligonucleotides (containing unique
barcodes), which serve as templates for traditional NGS libraries. The barcode on
each fragment will provide scaffold information for de novo assembly.

This innovative technology will transform genomics and have broad impacts
affecting all biological sciences, from genomic medicine to de novo sequencing of
large (mammalian sized) genomes. Specifically, the technology described here will
ultimately allow us to sequence, assemble, and phase the variants across entire
chromosomes.

Because the average length of our scaffold long reads is more than one megabase
long, we name our technology as Megabase Sequencing. In Chapter 3, surface
tagmentation, which is a newly developed library preparation approach on solid
surface and also the fundamental technique for Megabase Sequencing, are
elaborated. In Chapter 4, the experimental design and method of Megabase
Sequencing are described and discussed.

37

Chapter 3

Next Generation Sequencing Library Construction on a Surface

In this chapter, the detailed protocol for Tn5 expression and purification as well as
library preparation on surface will be described. An example of surface library
construction will be given and the results as well as several key questions will be
discussed.

3.1 Introduction
The Human Genome Project (HGP) is having a remarkable impact on the
biomedical community, primarily due to the amazing reduction in sequencing costs,
from $10 to less than $0.000001 per finished base in less than thirty years (85).
Exome sequencing is now routinely used in both research and clinical settings for
the detection of inherited or acquired mutations related to disease (86-91), and the
FDA has already listed over 100 drugs that have genotype information on their
labels (92). In addition, the use of whole genome sequencing is becoming more
widespread (93-98). However, the simplicity of the Next-Generation Sequencing
(NGS) pipeline could still be improved to further decrease the overall cost and
increase the impact of NGS technology. Herein, we describe an approach to
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generate NGS libraries directly on a flow cell surface, which will ultimately improve
the efficiency of the NGS pipeline.

Library preparation is the most important part in the whole NGS workflow. There
are a couple of different commercial kits available. Each of them is designed so
that the products are compatible with the corresponding sequencing platform.
However, the general process for different kits are essentially the same. They all
consist of three major steps: fragmentation, adaptor ligation, and amplification (99).
For fragmentation, a sonicator (e.g. Covaris) is usually used to breakdown large
DNA molecules into small fragments. A sonicator can shear DNA molecules
randomly but it is expensive and small labs may not have access to it. Therefore,
instead of shearing DNA in a mechanical way, people use restriction enzyme
(usually, a mix of several different enzyme are used) to fragment DNA. Although
restriction enzymes can be used for DNA fragmentation, sonication is still a better
choice because the mechanical shearing is almost random while the restriction
enzyme has preference, which limits the complexity of the final library. No matter
which method is used, the optimal size of the DNA fragments is obtained by
controlling the reaction time. After fragmentation, the ends of the DNA molecules
are fixed by Klenow (exo-), which generate blunt end with an extra “A” at 3’ end so
that sequencing adaptors can be added by A-T ligation. The adaptor sequences
not only serve as sequencing primer binding site, but also make the different DNA
fragments contain same end pairs so that they can be amplified by universal PCR
primers. Finally, with several cycles of PCR amplification, the flow cell (FC)
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adaptors as well as index sequence are added to the NGS library. There are also
PCR free kits, by which the FC adaptors are added along with sequencing
adaptors. It can take 8 to 10 hours of hands-on work to prepare a NGS library for
sequencing. Besides, column purification is usually required after each step, which
lead to the loss of a large quantity of DNA during the whole process. So, people
are trying to develop new approaches to prepare NGS libraries.

To streamline the NGS library preparation workflow and reduce sample loss,
Epicentre (acquired by Illumina) developed a new technique called tagmentation
(Figure 11). They use transposases to fragment DNA and ligate sequencing
adaptors simultaneously (12). By doing tagmentation, the whole library
construction process can be done within 2 hours and much less starting material
is needed. Basically, transposases attacks DNA and insert transposons randomly.
The 3’ OH group of transposons attack DNA and generate nicks, which allow the
whole transposons to be inserted. If sequencing adaptors are added to the 5’ end
of the transposons, they will be appended to the target DNA (100,101). By using
transposases, the conventional NGS library preparation procedure has been
simplified to just one reaction. The ideal size of the final library can be achieved by
adjusting the ratio of transposases and DNA. Generally, the more transposases
are used, the smaller the final DNA fragments will be.
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Figure 11. Overview of Nextera fragmentation and tagging technology.
(a,b) Using in vitro transposition, the starting DNA template is randomly
fragmented and tagged at sites indicated by red arrows, using standard transposon
ends (a) or transposon ends appended to unique adaptor sequences (colored bars)
(b) After suppression PCR, the library can be amplified and sequenced using the
appropriate platform-specific primers (102).
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Once NGS libraries are prepared, they need to form clusters on flow cells before
they can be sequenced. Therefore, if we can make the libraries on the surface (e.g.
flow cell), the whole process would be further simplified. Herein, we demonstrate
that sequencing libraries can be successfully generated on flow cell surface with
surface bound transposases. In this approach, DNA molecules are fragmented and
linked to the flow cell surface by the Tn5 transposases. The linked DNA molecules
are then ready for cluster generation. We believe our approach would simplify NGS
pipeline significantly and contribute to the goal of sequencing a genome within
$100.

3.2 Tn5 expression and purification

3.2.1 Overview
Commercial kits that are using transposases are available from Illumina (Nextera
Kit), but their expense limits their use especially when a large number of libraries
is needed. To solve this potential problem, Dr. Sandberg’s lab developed a simple
procedure to produce high quality Tn5 transposases and the performance is
comparable to Nextera kit (103). First, they cloned a hyperactive Tn5 allele into
pTBX1 plasmid. The allele they used contains two mutations which dramatically
increase the transposases binding and insertion efficiency. The pTBX1 plasmid is
used so that a chitin-binding domain (CBD) will be added to the Tn5, which is for
column binding and purification. After transforming pTBX1-Tn5 into M. xenopi,
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isopropyl beta-D-1-thiogalactopyranoside (IPTG) is added to induce the
expression of Tn5 transposases. Then all the lysates are loaded onto a chitin
column, which Tn5 fusion protein bind to through its CBD. To separate Tn5 from
CBD, DTT is used to cleave the cysteine at the C-terminal of Tn5. The Tn5 washed
off the column can be concentrated or used directly for making libraries. The
oligonucleotides that contain hyperactive mosaic end (ME) sequences and
adaptors sequences can be added while the Tn5 transposases are still on the
column, therefore, the Tn5 complex can be formed during purification, which
eliminates the free oligonucleotides in the final Tn5 solution. To remove the
genomic DNA from E. coli, polyethyleneimine (PEI) precipitation is done before
loading the cell lysates onto the chitin column.

Rather than using commercial transposase, we produced our own with the Tn5
plasmid made by Dr. Sandberg’s lab to decrease overall costs. We obtained the
Tn5 plasmid from Addgene and made our in-house transposases.

3.2.2 Materials and Methods
Acetic acid (Sigma, 695092)
Amicon Ultra-15 Centrifugal Filter Unit (Millipore, UFC903024)
Ampicillin (Sigma, A5354-10ML)
Chitin Resin (S6651S, NEB)
cOmplete, Mini, EDTA-free (Sigma, 4693159001)
Coomassie Brilliant Blue G (Sigma, B0770)
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DL-Dithiothreitol solution (Sigma, 43816-50ML)
EDTA, 0.5 M, pH8.0 (Sigma, 324504)
E-Gel™ EX Agarose Gels, 2% (ThermoFisher, G402002)
Glycerol (Sigma, EM4750)
HEPES (1 M) (ThermoFisher, 15630080)
Human Genomic DNA (Promega, G1521)
Isopropyl β-D-thiogalactopyranoside solution (Sigma, I1284-5ML)
LB broth media (VWR, 90003350)
LB broth with agar (Lennox) (Sigma, L2897-250G)
Magnesium chloride hexahydrate (Sigma, M2670)
Methanol (Sigma, 34860)
NuPAGE™ 10% Bis-Tris Protein Gels (ThermoFisher, NP0301PK2)
Poly(ethyleneimine) solution (Sigma, P3143-100ML)
Poly(ethylene glycol) (Sigma, 89510-250G-F)
pTXB1-Tn5 (Addgene, 60240)
QIAquick PCR Purification Kit (Qiagen, 28104)
Sodium azide (Sigma, S8032)
Sodium chloride (Sigma, S3014)
T7 Express lysY/Iq Competent E. coli (NEB, C3013I)
TAPS (Sigma, T9659)
Tris-EDTA buffer solution (Sigma, 93283)
TritionX-100 (Sigma, T9284)
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Oligonucleotide (IDT)
Tn5MErev
5'-/phos/CTGTCTCTTATACACATCT-3'

Tn5ME-A (Illumina FC-121-1030)
5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3'

Tn5ME-B (Illumina FC-121-1031)
5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3'

library PCR primers (Nextera Kit)
5'-AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

2x HEGX buffer
20 mM HEPES-KOH pH7.2
800 mM NaCl
1 mM EDTA
10% Glycerol
0.2% Trition-X100

2x Tn5 dialysis buffer
100 mM HEPES-KOH pH7.2
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200 mM NaCl
2 mM DTT
1 mM EDTA
20% Glycerol

2x Column buffer
40 mM Tris-HCl, pH8.5
1 M NaCl
2 mM EDTA (optional)

10x TAPS-MgCl2
100 mM TAPS
Add NaOH to pH8.3
50 mM MgCl2

5x TMgCl
50 mM Tris-HCl pH8.4~9.0
25 mM MgCl2

Stripping Buffer
40 mM Tris-HCl, pH8.5
1 M NaCl
2 mM EDTA (optional)
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0.3 M NaOH

Tn5 expression
pTXB1-Tn5 was acquired from Addgene. C3013 competent cells were used for
transformation and protein purification. After transformation, 10 colonies were
picked and cultured in LB media with ampicillin until the OD600 reached 0.9. 0.25
mM IPTG was added and let the cells grow for another 4 h at 23°C. Spin down and
remove the supernatants. Store the pellet at -80°C. The protein expression can be
checked by running the whole cell lysate on SDS-PAGE gel.

Tn5 purification
Prepare 5 ml chitin column and store the column at 4°C with column buffer.
Resuspend the cell pellet with HEGX and break the cells by sonication. Then spin
down and collect the supernatant. Add neutralized PEI to remove E. coli genomic
DNA. Spin again and load all the supernatant on to chitin column, wash the column
several times with HEGX. Then add 14 ml HEGX with 100 mM DTT and let it stay
at 4°C for 48 hours. Collect the fractions and dialysis with 2x dialysis buffer and
then quantified by NanoDrop.

Tn5 complex assembly
Anneal equal amount of 1 mM Tn5ME-A/B with 1 mM Tn5MErev separately at
44°C for 15 min and store at -20°C for future use. Assemble Tn5 complex by mixing
1 vol. of 55% Tn5 glycerol stock with 0.143 vol. of 100 mM MEDS-A/B, or mixing
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0.5 vol. of 50 µM MEDS-A/B, 1 vol. of 80% glycerol and 0.5 vol. of 50 µM Tn5 in
2x dialysis buffer, incubate at 37°C for 1 h and then store at -20°C.

Tn5 activity test
Prepare the tagmentation reaction mix ice. For a 20 µl reaction, add 2 µl of 10x
TAPS-MgCl2, 4 µl of 40% PEG8000, 50 ng of DNA and 1 µl of 12.5 µM Tn5
complex. Mix by pipetting and incubate at 55°C for 7 min. Stop the reaction by
adding 0.02% fresh SDS. Clean up the reaction with Qiagen PCR purification kit
and run the flow through on a 2% agarose gel.

Figure 12. Tn5 expression and purification.
10% SDS-PAGE run with crude lysate (lane 1), supernatant (lane 2), flow-through
(lane 3), and DTT eluted fractions from the chitin column. The expected sizes of
the Tn5 fusion protein (72 kDa) and cleaved full-length Tn5 (55 kDa) are indicated
on the right; marker molecular weights in kDa, to the left.
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3.2.3 Results
pTXB1-Tn5, which was constructed by Dr. Sandberg’s lab (103), was acquired
from Addgene. I expressed and purified the Tn5 transposases according to the
protocol (Figure 12). Tn5 activity was tested by doing tagmentation reaction in
solution with human genomic DNA. As shown in Figure 13, our home-made Tn5
successfully sheared genomic DNA. Tagmentation for different amount of time (7,
10, 15 or 20 min) demonstrated that longer incubation would generate smaller
fragments as expected.

Figure 13. Tn5 activity test.
50 ng of human genomic DNA was tagmented with our home-made Tn5 for
different amount of time at 55°C. Clean up the reactions with Qiagen columns and
run on 2% agarose gel.
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3.3 Library preparation with Tn5 on poly-acrylamide gel

3.3.1 Overview
In order to perform the tagmentation on a solid surface rather than in solution, we
first attached the transposases on a surface. A thin (~ 10 µm) polyacrylamide
hydrogel was used for the solid surface, as has been described previously for
cluster generation (104-106), and the Illumina flow cell also has a very thin
hydrogel layer on their flow cells (5). We designed two oligonucleotides which
contain the Illumina adapter sequences and a 19 bp mosaic end (ME) sequence,
which the transposases will recognize. The 5′ end of the oligonucleotides was
modified with an acrydite group to allow incorporation into the polyacrylamide gel
as it polymerized (Figure 14a), thereby linking the transposases to the surface
when the they bind the 19 bp ME (Figure 14b). We also included a 20-base oligo
dT spacer at the 5′ end of the oligonucleotides to make the ME more accessible to
the transposases. Once the transposases were assembled on the polyacrylamide
gel, genomic DNA and reaction buffer were applied to the surface to allow
simultaneously fragmentation and attachment to the surface. The tagmentation
reaction occurred at 55°C, after which the DNA is fragmented and attached to the
surface (Figure 14c).
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Figure 14. Tagmentation on surface.
(a) oligonucleotides are attached to a ~ 10 µm thick polyacrylamide gel. The 5’ end
of the oligos have an acrydite modification for attachment to the acrylamide matrix.
(b) The Tn5 transposases are assembled on the dsDNA oligos on the
polyacrylamide gel surface. (c) genomic DNA is linked to the surface through
tagmentation via incubation at 55°C for 20 min with TAPs buffer. (d), (e) side view
and vertical view of the linked DNA on surface.

3.3.2 Material and Methods
Acetic acid (Sigma, 695092)
Acrylamide/bis-acrylamide, 40% solution (Sigma, A9926)
Ammonium persulfate (Sigma, A3678)
Bind-Silane (GE Healthcare, 17-1330-01)
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DATD (Sigma, 156868)
Ethyl alcohol, Pure (Sigma, E7023)
Human Genomic DNA (Promega, G1521)
N,N,N′,N′-Tetramethylethylenediamine (Sigma, T7024)
Poly(ethylene glycol) (Sigma, 89510-250G-F)
QIAquick PCR Purification Kit (Qiagen, 28104)
SSC Buffer 20x (Sigma, 93017)
TAPS (Sigma, T9659)
Taq DNA polymerase (NEB, M0273S)

Oligonucleotide (IDT)
Tn5MErev
5'-/phos/CTGTCTCTTATACACATCT-3'

Acrydite oligo
5’-/Arcydite/20Ts--TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG
5’-/Arcydite/20Ts--GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG

Library PCR primers (Nextera Kit)
5'-AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

Prepare poly-acrylamide gel
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Salinize the glass slide with silane mix (0.02% Acetic acid, 0.4% Bind-silane,
purified water) overnight at room temperature. Wash several times with dH2O to
remove unbounded silane, rinse once with 100% ethanol, then air dry in a PCR
hood. Prepare 4% poly-acrylamide gel mix (4% Acrylamide / Bis [19:1], 10 µM of
acrydite modified primer, 0.1% APS and 0.1% TEMED) at room temperature. Add
5 µl of gel mix on silanized glass slide and put a 22 x 22 mm coverslip on top. Let
the gel polymerize for 30 min at room temperature. Remove the coverslip and
wash the gel with 0.5x SSC for 30 min to remove un-polymerized gel and primers.
Store the gel in 0.5x SSC for use.

Surface tagmentation
Take the poly-acrylamide gel slide out from 0.5x SSC and air dry completely. Mix
5 µl of 55% Tn5 with 5 µl of 1x TE and then add on to the gel. Put a coverslip on
top and incubate at 37°C for 1h. Transfer the gel slide to 4°C and let it sit for 3 min
while preparing the tagmentation reaction mix (1 µl of TAPs-MgCl2, 2 µl of
40%PEG8000, 300 ng of genomic DNA and nuclease free water up to 10 µl). Wash
the gel slide with Tn5 wash buffer to remove any unbounded transposases. Let it
dry at room temperature for a while and load the tagmentation reaction mix. Put a
coverslip on top and incubate at 55°C for 20 min.

Gel PCR and library purification
Wash the gel several times with purified water and let it air dry completely. Use a
clean razor blade to scrape off the gel and transfer to a 0.2 ml PCR tube. Prepare
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the PCR mix (5 µl of 10x standard Taq buffer, 1 µl of 10 mM dNTP mix, 2 µl of
PCR primer mix and 0.2 µl of Taq polymerase) and run with the following program:
68°C for 3 min, 95°C for 30 s, then 16 cycles of 95°C for 15 s, 63°C for 30 s and
68°C for 3 min. Clean up the PCR with Qiagen column and store the library at 4°C,
or run 5 µl of the library on a 2% agarose gel to check the quality.

3.3.3 Results
Two libraries were made with our home-made Tn5 on poly-acrylamide gel. 300 ng
of commercial genomic DNA was used for tagmentation on surface. Then the gel
was scraped off the slide and transferred to a PCR tube for 16 cycles of PCR. Final
libraries were purified and size-selected with AMpure beads. As shown in Figure
15, two sequencing libraries were successfully constructed on surface.
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Figure 15. Sequencing libraries made on poly-acrylamide gel.
(A) human genomic DNA (female) was used for library preparation on gel. PCR
products were purified and size selected with AMpure beads. Run on a 2%
agarose gel. The right lane shows the final library and the left lane shows the
fragments that were selected out. (B) A sequencing library made by human
genomic DNA (male).

3.4 Drosophila library preparation --- an example for surface tagmentation

3.4.1 Overview
To test our surface tagmentation, we attempted a sequencing library construction
with Drosophila genomic DNA and then sequenced on a MiSeq platform.

3.4.2 Material and Methods
Agencourt AMPure XP (Beckman Coulter, A63881)
Ethyl alcohol, Pure (Sigma, E7023)
MiSeq Reagent Kits v2 (Illumina, MS-102-2002)
Phenol – chloroform – isoamyl alcohol mixture (Sigma, 77617)
Phosphate buffered saline (Sigma, P5493)
Phosphate Buffer pH 7.0 (ThermoFisher, LC185201)
Qubit™ dsDNA BR Assay Kit (ThermoFisher, Q32850)
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Sylgard® 184 silicone elastomer kit (Dow Corning)
Tris-EDTA buffer solution (Sigma, 93283)
Tween® 20 (Sigma, 8.22184)
UltraPure™ 1 M Tris-HCI Buffer, pH 7.5 (ThermoFisher, 15567027)
YOYO™-1 Iodide (491/509) (ThermoFisher, Y3601)

Oligonucleotide (IDT)
Tn5MErev
5'-/phos/CTGTCTCTTATACACATCT-3'

Acrydite oligo
5’-/Arcydite/20Ts--TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG
5’-/Arcydite/20Ts--GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG

Library PCR primers (Nextera Kit)
5'-AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

Genomic DNA Isolation
Resuspend 3x106 drosophila cells in 150 µl of PBS and add 250 µl of warm
phenol/chloroform/isoamyl alcohol solution. Mix them by rotating at room
temperature for 10 min. Spin for 10 min at 14,000 rpm and transfer the top layer to
a new 1.5 ml tube. Add 10x volume ice cold 100% ethanol, mix by inverting several
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times. Do not pipet or vertex! Incubate the mix at -20°C overnight. Centrifuge for
30 min at 4°C with 14,000 rpm. Discard the supernatants and wash the pellet twice
with 80% ice cold ethanol. Air dry the pellet for 1~2 min at room temperature. Then
resuspend the pellet with 50 µl of 1x TE, quantify with Qubit and store at 4°C or 20°C.

Surface tagmentation and library preparation
The detailed protocol was described previously in this dissertation. Briefly, 4%
poly-acrylamide gel was made and 1 µM acrydite oligos were used when casting
the gel. Then, 5 µl of 55% Tn5 glycerol stock was loaded onto the gel and incubate
for 1 h at 37°C. After wash with Tn5 wash buffer, 300 ng of Drosophila genomic
DNA was used for tagmentation. After that, the library was extracted from the
surface by doing 16 cycles of PCR. Finally, the library was purified and sizeselected with AMPure beads (0.7x).

DNA combing
Prepare Polydimethylsiloxane (PDMS) in a 10 cm petri dish by mixing curing agent
and PDMS monomers at a 1:10 ratio, then incubate at 55°C overnight. Stain 1 µg
of genomic DNA (for commercial genomic DNA, it was aliquoted as 1 µg per tube
when arrived and stored at -80°C to avoid shearing) with diluted YoYo dye in 200
µl of phosphate buffered saline (pH 8.3) overnight at 4°C. Transfer 50 µl of
DNA/YoYo mix to a reservoir contains 1ml of PBS. Immerse PDMS coated
coverslip into the reservoir and incubated for 1 hour at room temperature. Then
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pull up the PDMS coated coverslip at 300 µm/s (Other speed was used to acquire
optimal results). Stretched DNA was visualized using an inverse fluorescence
microscope (Keyence).

MiSeq sequencing
The library was diluted to final concentration of 2 nM and 5% PhiX was spiked in
as control. Sequencing was performed on a MiSeq instrument with the Nano kit V2
in paired 150 bp mode (Illumina).

Data analysis
All sequencing reads were mapped to the reference genome using BWA (107).
The resulting bam file was sorted and indexed using samtools (108). Reads with
mapping quality lower than 30 were removed. PCR duplicates were dumped using
Picardtools. Coverage analysis was performed by homemade shell scripts.
Nextera sequencing data was downloaded from NCBI Sequence Read Archive
(SRA; http://www.ncbi.nlm.nih.gov/sra) under accession number ERR481289.

3.4.3 Results
First, the library was run on a 2% agarose gel, as shown in Figure 16c, the size of
the final library ranges from 200 bp to around 1 kb, which is adequate for
sequencing on an Illumina MiSeq. After sequencing, the resulting data was
mapped to the reference genome (109) with BWA. 97.3% of the reads were
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aligned to the reference genome with 1.8% PCR duplicates. Also, the reads
mapped uniformly across the Drosophila genome (Figure 17).

Figure 16. Drosophila sequencing libraries.
(a) and (b) Agarose gel (2%) demonstrating the PCR products from surface
tagmentation, various amount of acrydite oligonucleotides were used when casting
the poly-acrylamide gel. (c) Agarose gel (2%) demonstrating the sequencing library
after surface tagmentation and 16 cycles of PCR. The sequencing library was size
selected with Agencourt AMpure XP beads
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Figure 17. Sequencing reads distribution.
All reads were mapped to the reference genome with BWA while only reads with
mapping quality higher than 30 were used. Reads count was normalized to
chromosome length.

To further address sequencing bias, we down-sampled the data to 1.2x depth of
coverage and compared the actual breadth of coverage to the theoretical expected
value (Table 1). We then compared our library with the one made from a
commercial Illumina Nextera Kit, which used an in solution tagmentation technique
(Table 1). When the two libraries were analyzed at a similar sequencing depth, the
coverage is comparable, with the surface bound library being slightly better (58.5%
vs. 52.0%). Although the expected coverage at this sequencing depth should be
around 71%.
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Depth of

Breadth of

Expect Breadth

Coverage

Coverage

of Coverage

Surface tagmentation

1.249

58.5%

71.3%

Nextera Kit

1.272

52.0%

72.0%

Method

Table 1 Comparison NGS libraries made by surface tagmentation and
Nextera kit. Nextera data was downloaded from NCBI Sequence Read Archive
(SRA, ERR481289). Reads from our surface tagmentation and the Nextera data
were downsampled with Picardtools (PROBABILITY = 0.5) to have approximately
1.2× coverage. The expect breadth of coverage was calculated according to the
formula Cb = 1–1/eCd, where Cd stands for the depth of coverage while Cb stands
for the breadth of coverage

For NGS library preparation, the fragments size of the library is either decided by
the amount of enzyme or the time for sonication. With Nextera kit, the more
transposases are used, the smaller the finally library will be. However, with our
surface tagmentation, the situation may be different because all the enzymes are
fixed on the surface rather than moving around freely in solution. Therefore, one
would expect that the library quantity and the size of the fragments would be
related to the density of immobilized oligonucleotides, which controls the density
of immobilized transposases on the surface. In order to test this hypothesis and
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find out the best oligonucleotide concentration for making library on surface, we
generated sequencing libraries on multiple surfaces with oligonucleotide
concentrations of 0.1 µM, 0.5 µM, 1 µM, 5 µM, 10 µM, and 20 µM, and as shown
in Figure 16(a) and 16(b), the library molecules shifted to smaller sizes when we
increased the oligonucleotides concentration. We were not able to generate a
sequencing library with oligonucleotide concentrations below 1 µM (Figure 16a).
Tn5 transposases need to form a dimer to be functional and with such low
oligonucleotide density on surface, transposases are too far away from each other
to bind together.

Tagmentation has been favored over other NGS library preparation methods since
its implementation for requiring much less starting material. As little as 50 ng of
DNA is enough to generate a library in solution with tagmentation (13). However,
our approach requires 300 ng since the surface bound Tn5 reduces the DNA
collision frequency. In order to solve this potential problem, we used combed DNA
on a surface rather than DNA in solution. DNA combing is a technique to stretch
DNA on a hydrophobic surface by a receding air-water meniscus (110). Because
the polyacrylamide gel is not a hydrophobic surface, we first stretched DNA on
Polydimethylsiloxane (PDMS) and then transferred to the polyacrylamide surface.
As shown in Figure 18, the combed DNA molecules are kept stretched on
polyacrylamide gel after transferring. In this way, DNA molecules are more likely
to be captured by the transposases that fixed on the gel surface. Therefore, we
can use a much lower concentration of DNA. Another benefit for using combed
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DNA is that DNA molecules will be kept in their original shape with minimal
shearing. As can be visualized in Figure 18, these DNA fibers can be as long as
100 µm, which equals to approximately 200 kb. Once combed DNAs were
transferred to the polyacrylamide gel, they were tagmented by the transposases
and linked to the surface (Figure 18(e) and (f)). By using combed DNA, we could
generate a library with as little as 50 ng of DNA.

Figure 18. Combed DNA on a surface.
(a) and (b) YoYo-1 stained DNA stretched on PDMS. (c) and (d) Combed DNA on
poly-acrylamide gel before tagmentation. (e) and (f) Combed DNA on polyacrylamide gel after tagmentation
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3.5 Summary and Discussion
Library preparation is the first step in the NGS pipeline, and the process has been
standardized and several kits are commercially available. With these kits, a
standard sequencing library can be prepared in around 10 hours. The Nextera kit
from Illumina, which utilizes transposases to generate the sequencing library,
dramatically reduces the hands-on time to 2 hours by tagmentation (12), and this
kit can generate a good library for sequencing. However, the kit itself is expensive
and it still requires the sequencing library to be produced prior to injection to the
sequencing instrument. In order to make this technique more accessible to small
labs, Picelli and his colleagues made Tn5 transposases (103), which generate
comparable sequencing libraries to the Nextera kit. This allow researchers to
produce their own transposases for library preparation instead of purchasing the
Nextera kit. Using this enzyme, we have developed a method to generate DNA
libraries directly on a flow cell surface within the sequencing instrument. In our
approach, the Tn5 transposases are first attached to polyacrylamide gel surface,
which then fragments genomic DNA molecules and simultaneously links them to
the surface. We could generate clusters on the same surface with these linked
DNA molecules and directly sequence the clusters (111), This would significantly
simplify the whole library preparation and sequencing procedure. However, in this
study, we constructed a Drosophila genome library by surface tagmentation and
then extracted the library for sequencing to compare the overall performance of
surface tagmentation to solution-based tagmentation.
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Generally, the NGS library preparation requires 100 ng ~ 1 µg of genomic DNA to
start with while the Nextera kit only use 50 ng. While with our method, 300 ng of
genomic DNA was used. It is acceptable but not ideal if the DNA material is
precious or difficult to acquire. To overcome this shortcoming, we made use of the
DNA combing strategy and successfully reduced the starting amount to 50 ng.
DNA molecules were first combed on PDMS and then transferred to a flow cell
surface. We made the PDMS surface in advance, and it only took several minutes
to transfer the DNA from the PDMS to the flow cell surface. Ideally, we could comb
DNA directly on flow cell surface, however, the DNA combing process was not as
efficient on an acrylamide surface since it is hydrophilic. Two possible solution
would be replacing polyacrylamide gel with another hydrophobic surface or
optimizing combing conditions like, pH value, or salt concentration (112).

Overall, our surface tagmentation strategy produced the sequencing results that
are comparable to those prepared in solution, while significantly simplifying the
whole pre-sequencing library construction procedure. With DNA fragmented and
attached to the flow cell surface, the DNA molecules are ready for cluster
generation with no additional PCR amplification. To go one step further, the
surface tagmentation step could be automated in a sequencing instrument, and
the original DNA material can be loaded directly onto a sequencing flow cell without
any hands-on work.
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In this study, we developed an approach to generate DNA libraries directly on a
flow cell surface. With Tn5 transposase, we successfully generated a Drosophila
sequencing library by surface tagmentation and the performance was comparable
to the Nextera kit. Ultimately, our approach would allow cluster generation right
after the tagmentation without any PCR, which drastically simplifies the whole NGS
pipeline.
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Chapter 4

MegaBase Sequencing

4.1 Introduction
Next-generation DNA sequencing technologies have undergone extensive
improvements since the invention of the 454 sequencing platform in 2005 (4). With
tremendous progress in throughput, speed and a dramatic reduction in per-base
cost, DNA sequencing is widely used in basic science as well as translational
research such as clinical diagnostics. Exome sequencing is widely used in clinical
settings for the detection of inherited or acquired mutations in various disease
(87,113-116). And DNA sequencing is becoming a critical tool for precision
medicine (117-123). However, there are still major limitations of the current
technology which severely limit the feasibility and utility of whole genome
sequencing (WGS) for many studies. Namely, the read length of “Next-Generation
Sequencing” technologies is relatively short. The industry standard for sequencing
is arguably the Illumina HiSeq2500, which can sequence up to 4 billion paired 125
base reads per flow cell. With this relatively short read length, whole genome
resequencing studies are quite good at identifying single nucleotide variants (SNVs)
but are notoriously unreliable at identifying large insertions and deletions (indels)
and structural variants (124-128). It is also not possible to phase the variants using
short reads without considerable additional experimentation (49,56,62,129).
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There are long read technologies from Pacific Biosciences and Oxford Nanopore
that can disambiguate repeated sequences and structural variants by producing
reads as long as 50 kb (9,24). However, these technologies are significantly higher
in cost and error rates, and substantially lower in throughput than short read
technologies. Alternatively, Illumina and 10X Genomics developed synthetic long
read (SLR) technologies (68). They can generate long DNA fragments by
scaffolding accurate short reads with their unique barcode labeling system. But the
length of synthetic reads is still around 50 kb, which is not long enough for human
genome analysis (whole genome assembly, haplotyping, SVs detection etc.). Plus,
the library preparation process of these approaches are laborious and extra
instruments are needed.

Here, we demonstrate that sequencing library can be prepared on a DNA chip. By
using stretched DNA and barcode built-in DNA chip, our approach can provide a
more complete human genome sequence and allow whole genome studies to
accurately identify all variants and phase them to the appropriate homologous
chromosome. Our method starts by isolating megabase (Mb) long DNA and
combing them on DNA chip surface. Then the DNA are fragmented and linked to
oligonucleotides (barcode) on chip by transposases (tagmentation reaction). After
sequencing on NGS platform, the short reads are scaffold into Mb long contiguous
reads based on the barcode, which provide physical location information of each
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short read. With Mb long linked reads, MegaBase sequencing would allow
comprehensive understanding of human genome at much lower cost.

4.2 Library preparation with DNA in solution

4.2.1 Overview
To prepare the library on chip surface is similar to the library preparation on polyacrylamide gel except for the following differences. 1) The oligonucleotides on
surface are 5’ end up instead of 3’ end up. 2) The oligonucleotides are synthesized
while making the chip, so all of them will have only one adaptor sequence. 3) The
chip surface cannot be scrapped off and transfer into a tube for PCR amplification.
With all these differences, we modified our protocol of surface library preparation
and developed an approach to construct NGS library on chips. After the chips are
synthesized, we diced them into small pieces (1 mm x 0.25 mm) so that they will
fit into a 0.2 ml PCR tube. Then we can do all the reactions in the tube. For
transposases loading, we first assemble Tn5 in solution and then load the complex
onto chip surface, the 5’ overhang of mosaic end (ME) would hybridize to the
oligonucleotide on chip so that the Tn5 transposases are fixed on the surface.

As shown in Figure 19, the oligonucleotide on the barcode DNA chip contains
several parts: 15 base dT spacer, bottom adaptor (14 bp), barcode area (9 bp) and
top adaptor (15 bp). The 15 base dT spacer is designed so that the oligonucleotide
is longer and more accessible to Tn5 complex and genomic DNA. We tested
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different length of the dT spacer and found that the one with 15 bases produced
the best results. With the bottom adaptor, we designed primer accordingly to
amplify the final library. The bottom adaptor sequence is compatible with Illumina
sequencers so that no custom sequencing primer is needed when sequencing our
library on an Illumina platform. The top adaptor is used to capture Tn5 complex,
the sequence of which is complementary to the 5’ overhang of ME in the Tn5
complex. Once Tn5 complex is loaded to barcode chip, it would be fixed on the
surface by hybridization to the oligonucleotide on chip. Then, the tagmentation
reaction mix is added. After incubation at 55°C for 20 min, the DNA molecules
would be fragmented and attached to the oligonucleotide on chip surface. Next,
the 9 bp gaps that are generated during tagmentation are filled and the nicks
between Tn5 complex and the oligonucleotide on chip are fixed. Now, the library
molecules are complete and have sequencing adaptors at both ends, barcodes
and DNA fragment inserts. Finally, the library is extracted from the chip surface by
PCR amplification. There is another method to load Tn5 on chip for tagmentation
(Figure 20). The ME parts are first added to oligonucleotides on chip and then load
Tn5 transposases on at 37°C for 1 hour. This approach is similar to the protocol of
library construction on poly-acrylamide gel (described in Chapter 3 of this
dissertation).
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Figure 19. Library preparation on DNA chip I
(a) Oligonucleotide design on chip. There is a 15 bases dT serve as spacer.
Between top adaptor and bottom adaptor, there is 9 bp barcode, sequence as
“XXXCCCXXX” where “X” can be A, G, C or T. (b) Fix pre-loaded Tn5 on chip
through hybridization at 37°C for 40 min. (c) Surface tagmentation. Genomic DNA
and TAPs buffer are added onto surface and incubate at 55°C for 20 min. (d) Gap
filling and library PCR. T4 polymerase and E. coli ligase are used to fix gaps and
nicks. Then amplify the library with PCR primers for 21 cycles.

71

Figure 20. Library preparation on DNA chip II
(a) Chip design and ME hybridization. There is a 15 bases dT serve as spacer.
Between Hyb sequence and Adaptor B, there is 9 bp barcode, sequence as
“XXXCCCXXX” where “X” can be A, G, C or T. ME is designed with 5’ end
overhang, which contains Hyb sequence and Adaptor A. (b) Tagmentation with
DNA. (c) Fill the 9 bp gaps and the nicks. (d) Amplify with library PCR primers.

The DNA chips were synthesized by photolithography at Centrillion Biosciences
(Palo Alto, CA). We first tested our method on a chip with pseudo barcode (5 bases
random sequence), then we proceeded with a real barcode chip, which has 156
µm (10,000/4/4/4 ≈ 156) feature (every 156 µm2 has its own unique barcode), the
barcode is composed of 9 bases, the first 3 bases indicate the horizontal
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coordinate and the last 3 bases indicate the y coordinate. With these sequence
information, we can find its physical location on chip.

Figure 21. Affymetrix oligonucleotide microarray photolithography.
Photolithography: UV light is passed through a lithographic mask that acts as a
filter to either transmit or block the light from the chemically protected microarray
surface (wafer). The sequential application of specific lithographic masks
determines the order of sequence synthesis on the wafer surface. (Bottom)
Chemical synthesis cycle. UV lights removes the protecting groups (squares) from
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the array surface, allowing the addition of a single protected nucleotide as it is
washed over the microarray. Sequential rounds of light deprotection, changes in
the filtering patterns of the masks, and single nucleotide additions from microarray
features with specific 25bp probes (130).

4.2.2 Material and methods
Agencourt AMPure XP (Beckman Coulter, A63881)
Bovine Serum Albumin (Sigma, A2153)
E. coli DNA Ligase (NEB, M0205S)
E-Gel™ EX Agarose Gels, 2% (ThermoFisher, G402002)
Human Genomic DNA (Promega, G1521)
Klenow Fragment (3'-->5' exo-) (NEB, M0212S)
QIAquick Gel Extraction Kit (Qiagen, 28704)
QIAquick PCR Purification Kit (Qiagen, 28104)
Qubit™ dsDNA HS Assay Kit (ThermoFisher, Q32851)
Sodium dodecyl sulfate solution (Sigma, 71736)
Sodium hydroxide solution (Sigma, 72068)
TAPS (Sigma, T9659)
Taq DNA polymerase (NEB, M0273S)
Tn5 transposases (home-made)
T4 polymerase (NEB, M0203S)
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Oligonucleotide (IDT)
Tn5MErev
5'-/phos/CTGTCTCTTATACACATCT-3'

Tn5ME-A (Illumina FC-121-1030)
5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3'

Tn5ME-B (Illumina FC-121-1031)
5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3'

Bottom short primer
5’-GCTTCGGTCTGGCGG

library PCR primers (Nextera Kit)
5'-AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

library PCR primers (barcode chip)
5’-AATGATACGGCGACCACCGAGATCTACACGCTTCGGTCTGGCGG
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

Wash buffer
100 mM Tris-HCl [pH 7.5]
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100 mM NaCl
0.1% Tween 20

Working buffer
50 mM Tris-HCl [pH 7.5]
30 mM NaCl
0.1% Tween 20

Extension buffer
0.005% TritionX-100
10 mM Tris-HCl
5 mM MgCl2
7.5 mM DTT

Prepare pre-loaded Tn5
The detailed protocol for Tn5 expression and purification is described in Chapter
3. To make pre-loaded Tn5, the ME duplex was added when Tn5-CBD is still on
the column so that the Tn5 complex is formed during the purification steps. These
pre-loaded Tn5 are better than the post-loaded ones since there are no unbounded
ME duplex. We also noticed that the pre-loaded Tn5 works better than the postloaded ones as for DNA tagmentation in solution.

Library preparation on chip with pre-loaded Tn5
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Block the chip surface with 0.2 mg/ml BSA for 20 min at 37°C. Wash several times
with wash buffer and then incubate the chip with pre-load Tn5 for 30 min at room
temperature. Wash the chip several times with cold wash buffer. Then incubate
the chip with 400 ng genomic DNA in working buffer for 10min at 37°C. Add 11 µl
of 10x TAPS buffer for tagmentation at 55°C. Remove the Tn5 from genomic DNA
by 0.5% SDS. Fill the gap with T4 polymerase and E. coli ligase for 30 min at 37°C.
Wash several times with wash buffer and denature the DNA with 0.2 M NaOH.
Then anneal the bottom short primer and extend with Klenow for 1 h at 37°C.
Finally, amplify the library by PCR. The PCR program is as follows: 98°C for 30 s,
then 21 cycles of 98°C for 15 s, 63°C for 30 s and 72°C for 1 min. Purify and size
select the library with AMPure beads. Store the library in 1x TE at 4°C.

MiSeq sequencing
The library was diluted to final concentration of 2 nM and 5% PhiX was spiked in
as control. Sequencing was performed on a MiSeq instrument with the Nano kit V2
in paired 150 bp mode (Illumina).

Data analysis
All sequencing reads were mapped to the reference genome using Bowtie2 (131).
The resulting bam file was sorted and indexed using samtools (108). Reads with
mapping quality lower than 30 were removed. PCR duplicates were dumped using
Picardtools. Barcodes and library composition were analyzed with home-made
shell scripts and Python (Pandas).
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4.2.3 Results
As described in Chapter 3, our home-made Tn5 transposases are of high quality.
We can successfully generate a library from poly-acrylamide gel surface with the
Tn5 and its performance is comparable to the Nextera kit (132). Therefore, we
attempted to construct NGS library on chip with the similar approach. First, we
hybridized the complementary part to the oligonucleotides on chip to form the 19
bp double strand mosaic end (ME). Then load Tn5 so that they bind to the ME part.
However, we noticed that the efficiency of this step is very low. The reason could
be that the sequence of oligonucleotides on chip is of low accuracy. So very few
Tn5 complexes are formed on the surface. To solve this problem, we used preloaded Tn5, which binds to the oligonucleotide on chip through its 5’ overhang
hybridization (Figure 19).

First, we want to confirm that the pre-loaded Tn5 is still functional after fixing on
chip surface. We hybridized Tn5 complex onto chip and added genomic DNA for
tagmentation. Then we extracted tagmented molecules by PCR amplification. As
shown is Figure 22, there is a library after 21 cycles of PCR while for the negative
controls (no genomic DNA or no pre-loaded Tn5), there is no library. All these
indicate that our pre-loaded Tn5 were successfully fixed on the chip and they are
still functional on the surface. After tagmentation, the Tn5 enzyme needs to be
removed from the fragmented DNA to allow for the following enzymatic reactions.
0.5% SDS was used to denature and strip off the Tn5 transposases. We used a
78

much higher concentration of SDS here in order to completely remove the
transposases. Since we will wash the surface after the SDS treatment so that the
large amount of SDS will not affect the following reactions.

Figure 22. Optimization of protocol for library construction on chip.
(A) test of tagmentation with pre-loaded Tn5. No pre-loaded Tn5 in lane 1 and no
genomic DNA in lane 5. For lane 2, 3, 4, 6, 7 and 8, the amount of pre-loaded Tn5
is 0.5 µl, 1 µl, 2 µl, 0.05 µl, 0.1 µl and 0.5 µl. After tagmentation, the libraries were
amplified by PCR and run on a 2% agarose gel. (B) Gap-filling test. There is no
gap filling in lane 1, PreCR kit was used for lane 2, T4 DNA polymerase and E. coli
ligase were used for lane 3. After gap filling, library molecules are denatured by
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NaOH and amplified by PCR, and run on a 2% agarose gel. (C) Libraries prepared
on chip with (lane 3 and 4) or without (lane 1 and 2) Klenow extension.

There is a 9 bp gap after tagmentation and a nick between Tn5 complex and
oligonucleotide on chip (Figure 19). We need to fix these gaps and nicks before
we can amplify the library molecules. People usually use PreCR kit to fix these
DNA damages, while there are also people using the combination of T4 DNA
polymerase and E. coli ligase to fill gaps. We tried both methods and treat with
NaOH to remove un-fixed fragments afterwards. Then quantify the total fixed
molecules by PCR amplification to evaluate the efficiency of the two methods. The
results are shown in Figure 22. T4 DNA polymerase and E. coli ligase worked
better as there are more ligated DNA fragments. Also, we noticed that there is Bst
DNA polymerase in the PreCR enzyme mix, which could potentially mess up our
library preparation on the chip surface due to its strong strand displacement activity.
Therefore, we choose to use T4 DNA polymerase and E. coli ligase in the following
experiments. Even though the two enzymes require different reaction buffer, we
found that both enzymes work just fine in the E. coli ligase buffer plus some BSA.
We also optimized the reaction time and temperature. 30 min incubation at 37°C
is sufficient to fix the gaps and nicks.

As shown in Figure 19, we are able to do PCR and extract libraries from the surface
after we fix the gaps and nicks. However, we can barely get a library after 21 cycles
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of PCR (Figure 22). The possible reason could be that the oligonucleotides density
is too high on chip surface while the PCR primer is relatively long (> 43 bp).
Therefore, the primers have nearly no access to the hybridization part, which
prevents them from initiating the extension reaction. To solve this problem, we
added an extra step before the final PCR. A short bottom primer (15 bp), which
does not contain the FC (flow cell) sequence, was used to anneal and extend with
a relatively small polymerase (Klenow [exo-]). By doing this extra step, we made a
duplicate of the library on surface and they are not linked to chip directly. And when
denatured during the first cycle of PCR, these copies are released to the solution
from the surface and make themselves more accessible to the long PCR primers
as well as the DNA polymerase. So, the surface reaction is converted to an insolution reaction. As shown in Figure 22, we were able to obtain libraries after
Klenow extension with short bottom primers.

The final library was loaded onto a MiSeq sequencer with a MiSeq Nano kit. All the
reads are mapped to the human genome and the pseudo barcode (5 random
bases) can be found in most of the reads. All these indicate that the genomic DNA
molecules were fragmented and linked to the oligonucleotides on chip by surface
tagmentation with home-made pre-loaded Tn5.

Next, we moved on to apply our surface tagmentation protocol to a real barcode
chip. The chip was synthesized with a 156 µm feature. Each chip is 1 cm x 1 cm
and within the chip, every 156 µm2 has its unique barcode. When preparing
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libraries on the barcode chip, the chip was diced into smaller dimension (1 cm x
0.25 cm) so that it fits into a 0.2 ml PCR tube. A library was prepared and
sequenced on MiSeq platform. We noticed that we got fewer reads than expected
and the cluster density is much lower than expected. For this problem, we
hypothesized that some of the library molecules are mis-primed products. Because
we did the extra extension with a short primer before final PCR and the short primer
can possibly anneal to somewhere within the inserted genomic DNA rather than
the bottom adaptor (Figure 23). Therefore, when these mis-primed products get
amplified by PCR, they would result in the molecules that contain both FC
sequences but missing one of the sequencing primer binding site. So, when
quantified the library with qPCR, these library molecules are counted, and they can
also form clusters on the surface. But they cannot be sequenced as the
sequencing primer binding sites are missing. So, no fluorescent dNTP can
incorporate, which makes these clusters invisible. To solve this problem, we
designed another chip with longer bottom adaptor, which allows us to extend from
the lower region and PCR from the upper region (Figure 23). Therefore, only the
correctly extension products would be amplified.
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Figure 23. Mis-priming issue with Klenow extension.
(a) illustration of the correct priming where the short bottom primer (red) binds to
the bottom adaptor on chip. (b) illustration of the mis-priming where the short
bottom primer binds to somewhere within the insertion part (light grey). (c) new
design of the oligonucleotides on chip with longer bottom adaptor (red). The short
bottom primer would anneal to the bottom part of the primer and the PCR primer
would start from the upper part to avoid amplifying mis-primed extension products.

Figure 24. Sample reads from MiSeq sequencing.
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20 reads were extracted from FASTQ file of Read 3. Red sequences indicate the
bottom adaptor. Green sequences indicate the top adaptor and the yellow regions
are barcode.

With the new version of barcode chip, we generated a library with commercial
human genomic DNA and sequenced on MiSeq sequencer. When all the
sequencing reads are aligned to human reference genome, the majority of the
reads (98.3%) were successfully mapped to the reference and almost all of them
are correctly structured (>99%), which indicates that each DNA fragment is linked
to a unique barcode (Figure 24). After analyzing these barcode and mapped reads,
we found that the DNA molecules that have the same barcode tend to locate in
nearby regions in the genome (Figure 25). Therefore, we can make use of these
physical location information contained in the barcode to help scaffold the short
reads.
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Figure 25. Preliminary data showing reads are scaffolded.
This figure was generated by: 1. Create separate FASTQ files for each barcode
and map the reads to the genome. 2. Sort the resulting BAM file. 3. Generate a list
of distances between all adjacent mapped reads. 4. Randomly down sample all
the data (from all barcodes) to the same number of reads as with a single barcode
and generate the same list of distances between all adjacent mapped reads. 6.
plot the data - single barcode (Y-axis) vs. all barcodes (X-axis). Note, we have a
separate figure for each barcode, and here one representative example is shown.
All figures show the same feature, reads from the same zip code are biased to be
closer together.
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In summary, we optimized our surface tagmentation protocol and generated a
library from barcode chip. Our home-made pre-loaded Tn5 can fragment genomic
DNA and link the fragments with the oligonucleotides on surface. The barcode on
the chip can help scaffold the short sequencing reads and contribute to complete
genome assembly.

4.2.4 Discussion
Next Generation Sequencing (NGS) has been around for more than 13 years and
library preparation is the most important part for NGS. Numerous different
approaches have been developed and some are made commercially available.
However, no matter what technique is used, the relatively short reads are still
problems for the downstream data analysis. One of the challenges is the multiple
alignment. As the reads are too short and there are many repeated regions, it
would be very difficult to map the read to its original position. Should there be a
way to label all the DNA fragments before sequencing, this problem would be
solved. Here, we developed an approach, which use barcode chip to mark the
DNA while at the same time making fragments by using Tn5 transposases. So,
every DNA fragment is trackable by just referring to the barcode it is linked with.
With this method, we successfully generated a library on a barcode chip and our
data indicate that each DNA library molecule is linked to a unique barcode. In
addition, the DNA library molecules that share the same barcode tend to originate
from the nearby region on genome. By using this approach, we can scaffold short
reads into long blocks and make the downstream data analysis much easier.
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As we tried to prepare libraries on barcode chip, we noticed that the high density
of oligonucleotides on chip is a big problem for us. It not only affects the Tn5
loading efficiency, but also prevent the binding of PCR primers. With polyacrylamide gel, we can easily adjust the density of oligonucleotides on surface.
However, it is very difficult to change the density of oligonucleotides on chip as
they are synthesized by machine. To deal with this issue, we changed our way to
load Tn5 transposases. We first generated the pre-loaded Tn5 and then anneal to
the chip surface by hybridization. And this turned out to work well. We also add an
extra step before the final library PCR, in which we used a short primer and extend
with Klenow. This extra step solved the problem and we successfully generated a
library from a DNA chip. However, the mis-priming during the extension also cause
problem. The short primer can bind to somewhere within the genome and extend
from there (Figure 23). Therefore, these library molecules would not have the
sequencing primer binding site and the barcode. To make it even worse, these
“junk” library molecules make up a majority portion of the final library and they
could form clusters on the flow cell but would not be sequenced, which makes the
usable sequencing data very minimum. We solved this problem by increasing the
length of bottom adaptor so that we can extend from the lower region and amplify
from the upper region (Figure 23). Therefore, only the correctly primed extension
products would be amplified.
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To prepare NGS libraries, DNA amount is a critical thing to consider. It is always
better to use minimum starting material for the library preparation because often
times, the DNA is very precious and only a small amount is available. For a
standard DNA sequencing library preparation protocol, around 100 ng of DNA is
needed. With Nextera kit, 50 ng of DNA is enough. However, we used 500 ng of
DNA to prepare library on a barcode chip. Even though we also used transposases,
our surface tagmentation is less efficient than the tagmentation in solution. It turned
out that this is because of the low DNA binding efficiency. In fact, only a small
portion of 500 ng DNA linked to the oligonucleotides on chip surface. The majority
of the DNA molecules are just floating around in the solution. Because the Tn5
transposases are fixed on the surface, they are less likely to capture the DNA
molecules in the solution. A rotator may help to increase the reaction efficiency but
still cannot reduce the starting material to 50 ng. As we tested the surface
tagmentation on the poly-acrylamide gel, DNA combing was used to bring the DNA
and Tn5 complex together, which significantly reduced the amount of DNA for
library preparation. We may try the same solution on our library preparation with
barcode chip. I’ll describe how to use combed DNA to prepare library on barcode
chip in details in the next part of this chapter.

In conclusion, we developed an approach to label genomic DNA before
sequencing, which could help scaffold short reads and make the following data
analysis easier. Surface tagmentation on barcode chip perfectly merges the three
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key parts of NGS library preparation (fragmentation, adaptor ligation and indexing)
into one single step, which significantly simplified the whole procedure.

4.3 Library preparation with combed DNA

4.3.1 Overview
It has been a big challenge for sequencing data analysis since NGS developed.
The relatively short length of the reads and the repetitive regions in the genome
make it very difficult to assign the reads to their original position. People have
developed several solutions, for example, long reads sequencing (9,133),
synthetic long reads (68) etc. Each of these technologies has its own pros and
cons. For example, the long reads technologies produce relatively long reads
which provide valuable long-range information, but they are too expensive, and
their raw reads are of low quality. The synthetic long read approaches come with
high accuracy reads and throughput. However, they require extra steps, which
makes the whole library preparation process laborious. Here, we developed a way
to prepare NGS library on a barcode chip with super long DNA fragments, which
simplified the protocol and requires no extra device or equipment. More importantly,
our technology has the potential to provide more complete genome information. In
the last part, I described how we can prepare library with DNA in solution on a
barcode chip. Here, the combed DNA will be used to acquire much more location
information during the library preparation.
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The length of DNA fragments is the key parameter affecting genome phasing
performance (134,135). For example, 10X Genomics technology is better than
Illumina’s synthetic long read approach. 10X Genomics starts with longer (50 kb
vs 10 kb) DNA fragments so that they can cover more SNPs and generate longer
haplotype blocks. In order to improve the performance, the DNA fragments need
to be even longer to several megabases. However, it’s difficult to obtain DNA
fragments larger than 10 kb with the traditional column-based DNA isolation kit
because there is excessive shearing during the purification (136). There are also
commercial kits (Qiagen Gentra Puregene kit and Agilent DNA Extraction kit)
which could produce 500 kb long DNA fragments but still cannot meet our
requirement. Therefore, we decided to extract DNA from cells by making DNA
plugs. Basically, cells are imbedded in agarose gel and digested with proteinase
K, then the agarose is removed by enzyme and DNA is released into solution. The
DNA fragments can be as long as 50 Mb, which is ideal for our library preparation
method.

Molecular combing is a process through which free DNA in solution is placed in a
reservoir, and a hydrophobic-coated coverslip is dipped into the DNA solution and
retracted at very low speed (~300 µm/s). While the physics of the process is not
fully understood, it is thought that the DNA ends interact with the surface of the
coverslip through hydrophobic interactions, and the process of retracting the
coverslip produces a receding meniscus which pulls the DNA in a linear fashion
(110). This highly parallel process produces high-density packed long DNA
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molecules stretched on a surface (Figure 26). The DNA fibers generated by this
technique can be as long as 50 Mb (137). Once the combed DNA molecules are
tagmented on chip, they can be labelled with unique barcode accordingly. The
physical location information provided by the barcode could help scaffold the short
reads. The scaffolds generated in this way would be much longer than using noncombed DNA.

Figure 26. DNA combing.
(a) Principle of DNA combing: DNA fibers are stretched on a silanized coverslip by
a receding air-water meniscus (138). (b) YoYo-1 stained DNA combed on PDMS.

As previously discussed, the combed DNA could also increase the surface
tagmentation efficiency, which reduces the amount of DNA that is needed. Rather
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than floating around in solution, the combed DNA would stick to the chip surface
and make themselves close enough to be captured by the transposases nearby.

4.3.2 Material and methods
Agencourt AMPure XP (Beckman Coulter, A63881)
Bovine Serum Albumin (Sigma, A2153)
β-Agarase I (NEB, M0392S)
CHEF Genomic DNA Plug Kits (BioRad, 1703591)
E. coli DNA Ligase (NEB, M0205S)
E-Gel™ EX Agarose Gels, 2% (ThermoFisher, G402002)
Human Genomic DNA (Promega, G1521)
Klenow Fragment (3'-->5' exo-) (NEB, M0212S)
QIAquick PCR Purification Kit (Qiagen, 28104)
QIAquick Gel Extraction Kit (Qiagen, 28704)
Qubit™ dsDNA HS Assay Kit (ThermoFisher, Q32851)
Sodium dodecyl sulfate solution (Sigma, 71736)
Sodium hydroxide solution (Sigma, 72068)
Sylgard® 184 silicone elastomer kit (Dow Corning)
TAPS (Sigma, T9659)
Taq DNA polymerase (NEB, M0273S)
Tn5 transposases (home-made)
T4 polymerase (NEB, M0203S)
YOYO™-1 Iodide (491/509) (ThermoFisher, Y3601)
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Oligonucleotide (IDT)
Tn5MErev
5'-/phos/CTGTCTCTTATACACATCT-3'

Tn5ME-A (Illumina FC-121-1030)
5'-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3'

Tn5ME-B (Illumina FC-121-1031)
5'-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3'

Bottom short primer
5’-GCTTCGGTCTGGCGG

library PCR primers (Nextera Kit)
5'-AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

library PCR primers (barcode chip)
5’-AATGATACGGCGACCACCGAGATCTACACGCTTCGGTCTGGCGG
5'-CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG

Wash buffer
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100 mM Tris-HCl [pH 7.5]
100 mM NaCl
0.1% Tween 20

Working buffer
50 mM Tris-HCl [pH 7.5]
30 mM NaCl
0.1% Tween 20

Extension buffer
0.005% TritionX-100
10 mM Tris-HCl
5 mM MgCl2
7.5 mM DTT

Cell culture
Dr. Church’s fibroblast cells (skin, arm) were obtained from Coriell Institute
(GM23248). Cells grow medium is Dulbecco’s Modified Eagle’s Medium/Nutrient
Mixture F-12 Ham, supplied with 2 mM L-glutamine (25030081, Life Tech), 15%
Newborn Calf Serum Not inactivated (26140079, Life Tech), 10 ng/ml Epidermal
Growth Factor (E4127-.1MG, Sigma), 1% Non-Essential Amino Acids (M7145100ML, Sigma). Cells grow at 37°C with 5% CO2
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Isolate long DNA molecules
BioRad Mammalian Genomic DNA Plug Kit was used to acquire long DNA
molecules. Resuspend 1 million cells in PBS and spin down to get cell pellet. Add
630 µl of cell suspension buffer and mix with 370 µl of 2% CleanCut agarose
solution. Then transfer the mix into plug molds, 100 µl per plug. Wait until the
agarose solidifies, then treat the DNA plug with proteinase K overnight at 50°C.
Wash the plugs several times with wash buffer and then store at 4°C or proceed
to extract DNA from plug. Wash the plugs 3 times with 1x TE and 1 time with MES
solution. Then melt the plug at 70°C for 20 min. Digest the agarose with β-agarase
I overnight at 42°C. Let the DNA stay in 4°C for one or two days before stretching.

DNA combing
Prepare polydimethylsiloxane (PDMS) in a 10 cm petri dish by mixing curing agent
and PDMS monomers at a 1:10 ratio, then incubate at 55°C overnight. Stain 1 µg
of genomic DNA (For commercial genomic DNA, it was aliquoted as 1 µg per tube
when arrived and stored at -80°C to avoid shearing.) with diluted YoYo dye in 200
µl of phosphate buffered saline (pH 8.3) overnight at 4°C. Transfer 50 µl of
DNA/YoYo mix to a reservoir contains 1 ml of PBS. Immerse PDMS coated
coverslip into the reservoir and incubated for 1 h at room temperature. Then pull
up the PDMS coated coverslip at 300 µm/s (Other speed was used to acquire
optimal results). Stretched DNA was visualized using an inverse fluorescence
microscope.

95

Library preparation on chip with combed DNA
The general protocol is the same as previously described in the last part of this
chapter except that combed DNA was used here. Briefly, barcode was blocked
with BSA and then pre-loaded Tn5 was fixed on surface. Stretch isolated long DNA
on PDMS and transfer to the chip surface. Incubate with TAPS buffer at 55°C for
20 min. Fill the gap with T4 polymerase and E. coli ligase. Then anneal the bottom
short primer and extend with Klenow at 37°C for 1 h. Extract the library molecules
from the surface by PCR, the program is as follows: 98°C for 30 s, then 21 cycles
of 98°C for 15 s, 63°C for 30 s and 72°C for 1 min. AMPure beads were used to
final library purification and size-selection. The library can be stored at 4°C.

DNA sequencing
The library was diluted to final concentration of 2 nM and 5% PhiX was spiked in
as control. Sequencing was performed on a MiSeq instrument with the Nano kit V2
in paired 150 bp mode (Illumina).

4.3.3 Results
We first extracted super long DNA molecules with BioRad Mammalian Genomic
DNA Plug Kit and then tried to stretch them directly on a DNA chip with our homemade syringe pump. Unfortunately, there are very few combed DNA on chip
surface after stretching. The reason could be that the chip surface is not super
hydrophobic. Therefore, we attempted to stretch DNA molecules on a different
surface (hydrophobic surface, e.g. PDMS) and then transfer onto chip. As shown
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in Figure 26, the stretched DNA are super long and are usually more than 1 Mb.
We transferred combed DNA from PDMS to chip by just taking two surfaces
together and making a “sandwich”. Most of the DNA molecules would transfer to
chip surface after 10 seconds pressing. Actually, we need to transfer combed DNA
after loading Tn5 complex onto chip surface so that the transposases can capture
DNA molecules right after transferring without affecting the stretched status (Figure
27). So, after transferring, we added tagmentation reaction mix and incubate the
chip at 55°C for 30 min. Then fill the gaps and nicks followed by several cycles of
PCR to acquire the final library. We successfully generated a NGS sequencing
library on chip with the combed DNA as shown in Figure 28. We also did some
quality control experiments to confirm that the library is of high quality. As our
library should contain both sequencing primer (SP) part and flow cell (FC) part, we
did PCR with the final library with either SP or FC primers. As shown in Figure 28,
the amount of PCR products from both primers are comparable to each other,
which indicates that the library molecules are correctly formed with very minimum
mis-priming.
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Figure 27. Combed DNA on PDMS and chip surface.
(A) YoYo-1 stained human genomic DNA stretched on PDMS (B) YoYo-1 stained
DNA transferred to chip after combing on PDMS.
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Figure 28. Sequencing libraries from barcode chip.
(A) Two sequencing libraries made on barcode chip with stretched DNA, run on a
2% gel after purification and size-selection with 24 (lane 1) or 26 (lane 2) cycles of
PCR. (B) Library QC products run on 2% agarose gel. Original library with 21
cycles of PCR shown in lane 1. Take 1 µl of the library and PCR for 9 more cycles
with either FC (lane 2) or SP (lane 3) primers.

4.3.4 Discussion
Synthetic long read (SLR) technologies are ideal tools to analyze the human
genome by using short-read sequencing platforms to generate long reads. Here
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we increased the read length to several megabase, which is the same order of
human chromosome length. With such long reads, we would be able to fill most of
the gaps, resolve all the SNPs and provide complete human genome information.
By using DNA combing, surface tagmentation and barcode DNA chip, we
developed a barcode labeling approach that is much simpler than previous SLR
methods.

Though we obtained a library from DNA chip with combed DNA, the amount of
combed DNA is not optimal as we can tell from the low density of stretched DNA
on chip (Figure 27). Ideally, we can stretch 30~40 equivalent genomic DNA on a
single chip to maximize the surface utilization. There are a number of variables
that influence the density of combed DNA. Two critical variables are the surface
characteristics and the chemical composition of the buffer (112). pH value of the
buffer is one of the key parameter. Bensimon’s group reported that DNA can only
be stretched on hydrophobic surface (vinyl-silane coated glass) near a pH value
of

5.5 (138) while

Benke’s lab has successfully stretched DNA on

polydimethylsiloxane (PDMS) with a pH value ranging from 4 to 10. And they
obtained highest density of combed DNA at pH 4 (112). NaCl concentration of the
buffer also affect the combed DNA density. Within certain concentration range, the
density of combed DNA increases as salt concentration goes up (112). At 100 mM
NaCl, combed DNAs reach highest density and the density will decrease
significantly if the NaCl concentration goes over 1000 mM. Another important
factor is combing speed. DNA ends attach to the surface through hydrophobic
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interaction and it is the water-air interface that stretches coiled DNA from solution
onto surface. The combing speed plays a major role in determining these forces,
which will affect the length as well as the density of combed DNA (139).

Figure 29. pH-dependent adsorption of DNA molecules on hydrophobic
PDMS surfaces
((a) pH 2, (b) pH 3, (c) pH 4, (d) pH 6.2, (e) pH 9, (f) pH 10). In the whole pH range
from 4 to 10, a large number of molecules are adsorbed and stretched. At pH 4
there is an extremely high density of stretched molecules. At pH values smaller
than 4, adhesion is too strong to allow combing of the molecules (112).

Due to the inefficiency of chip synthesis, there are some truncated oligonucleotides
on the surface (140), which not only makes it difficult to load Tn5 complex, but also
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impede the construction of correct library molecules during PCR. To solve this
problem, we developed a method called “chip printing”, by which the barcodes can
be transferred from chip to a poly-acrylamide gel surface (Figure 30). Then we can
prepare our library on gel (as I described in chapter 3). When printing the chip,
only the fully synthesized oligonucleotides can transfer to the chip so that the
truncated ones would be selected out. However, the efficiency of chip printing is
low due to various reasons and less than 1% oligonucleotides could be
successfully transferred. In fact, high-density oligonucleotide chip of probe lengths
up to 60 bp are commercially available from Affymetrix, NimbleGen and Agilent
(141-143). However, the smallest feature pitch fabricated in these chips is 5 µm,
13 µm and 30 µm respectively. Ideally, the barcode regions should be <1 µm, such
that each feature spans a 2000 bp section of stretched DNA.
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Figure 30. Chip printing.
(a) Oligonucleotides on chip surface with 5’ end up, which contains spacer (black),
bottom adaptor (red), barcode (yellow) and top adaptor (green). (b)
Oligonucleotides on poly-acrylamide gel surface with 3’ end up, which contains
spacer (black) and top adaptor (red), the top adaptor is complementary to the
bottom adaptor on chip. (c) Printing the sequence from chip to acrylamide gel by
making “sandwich” and extending with Bst polymerase. The two surfaces are
separated by hot water denature after printing (d). The gel after printing would
contain both top and bottom adaptor as well as barcode.
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In conclusion, we developed an approach to prepared NGS library on DNA chip
with super long combed DNA. The barcode DNA chip allow fast and high efficiency
barcode labeling and the megabase long synthetic reads generated by this method
would dramatically improve the completeness of phased genome assembly. Since
our library is prepared directly on a solid surface, we can incorporate our chip into
Illumina’s flow cell and generate clusters on the same surface.

4.4 Summary and Discussion
The sequencing market has been dominated by NGS for more than 10 years. With
relatively low per base cost and high throughput, NGS has been widely used in
basic research as well as clinical diagnoses (144-152). However, it is still a
challenge to acquire a complete human genome sequence. The long-range
information is often missing due to the short length of NGS reads, which leaves
many gaps in between scaffolds rather than an entire piece for each chromosome.
Moreover, without the long-range information, haplotype-resolved genome
sequencing and structural variant detection is nearly impossible. However, it is
critical to understand the genetic basis of complex phenotypes with haplotype
information. The complex structural variations are always involved in numerous
disease, such as cancer. Large fragment translocation, inversion and deletion are
usually the cause of cancer, and can be used for early cancer diagnoses (153157). Unfortunately, most of current technologies failed to provide this information.
There are methods can resolve some of the SNPs and SVs but they are either
expensive or of low accuracy or low throughput. Here, we described an approach
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to generate super long reads (several megabase) with very high accuracy and
comparable cost to standard NGS. Megabase long DNA molecules are extracted
from cells and combed on surface. Then the library is constructed on a DNA
(barcode) chip. With the physical location information provided by the barcode,
short sequencing reads can be easily scaffolded into a megabase long read.

Our method has three major advantages over previous approaches. First, we start
with megabase long DNA fragments for library preparation. These nearly unsheared DNA fragments could reserve each SNP’s location very well and allow
megabase long read scaffolding after sequencing. It is shown that longer reads
would provide much more genome information and require less sequencing
coverage, which would substantially decrease the overall cost (40). Second, the
library is prepared on surface with in-house transposases, which simplified the
whole library construction process by tagmentation and reduced total cost by using
home-made enzymes. Also, the tagmented DNA can be used for cluster
generation directly on the same surface and this would allow hands-free library
preparation in the future. In addition, because of the character of Tn5 transposases,
there is 9 bp overlap between adjacent reads, which can be used to link all the
reads and make the genome assembly easier (158). Third, the DNA chip provides
a perfect barcode labeling system. Rather than partitioning the DNA fragments
before library preparation, the whole genome is labeled during tagmentation, which
makes every piece of DNA fragment trackable after sequencing. There is no
additional step needed to add barcode. One would argue that our approach is
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similar to 10X Genomics’ method, however, our technology has many advantages:
1) 10X Genomics linked read technology generate libraries relies on whole
genome amplification (WGA), which could cause some bias in the data. We do not
require WGA. 2) 10X Genomics requires the purchase of a ~$120K instrument.
We do not require extra instruments. Instead we need a DNA chip which is a cheap
disposable consumable reagent. 3) 10X Genomics can only identify that all short
reads sharing same barcode came from nearby regions on a chromosome, while
we can scaffold (or order) the reads along the entire chromosome. 4) The fragment
size spanned by linked reads is ~100 kb for 10X Genomics. We have many
molecules greater than 1 Mb in our approach.

The chip we used in this study is an early version, which has relatively big features
(~156 µm, or ~4,000 different barcodes). Therefore, chances are that reads share
the same barcode may not come from the same megabase long fragment because
there are too many genome fragments in each virtual compartment. We may need
some complicated computational algorithm to resolve this problem. Alternatively,
chips with small features (1 µm) are preferable. With such small feature, fewer
reads will share the same barcode and they are more likely to originate from the
same fragment. In addition, there are only 6 bp in the barcode area, which makes
demultiplexing very difficult because of the high error rate during chip synthesis.
To deal with problem, we can increase the length of barcode and make each
barcode to be at least four edit distance apart, or in other words, four deletions or
insertions or substitutions away from any other barcode on chip. Also, the
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sequence of barcodes will be designed such that they can be accurately
sequenced, which means there will be no homopolymer longer than two bases, no
self-complimentary longer than three bases and there is 40% to 60% G or C bases.

In summary, we developed an approach to prepare NGS library on a DNA chip
with stretched DNA. The megabase long reads produced by our method will
ultimately allow us to assemble and phase the variants across entire chromosomes.
With high accuracy, high throughput and low cost. Our technology will transform
genomics and have impacts in the biological sciences, from personalized medicine
to de novo sequencing of human genome.
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Chapter 5

Summary and Future Perspectives

Since the 454 sequencing platform was introduced in 2005, many different
sequencing technologies have been developed (5,6,9,159-163). From Illumina’s
short-read sequencing to PacBio’s long-read sequencing, all contribute to every
single area of genomic research and clinical investigation. The rapid development
of sequencing technology leads to a better understanding of our genome and many
solutions to medical problems. In previous chapters, I described two technologies
we developed for DNA sequencing. One is a simple way to prepare NGS library
on a solid surface. The other is an approach to generate megabase long synthetic
reads with DNA chips. I will first summarize these two approaches in this chapter
and then discuss their applications for RNA sequencing and methylation
sequencing as they are also important parts for genomic research. Finally,
genomic medicine and how our technology can contribute to cancer detection and
treatment, prenatal screening and rare genetic disease diagnosis will be discussed.

5.1 Summary
Library preparation is a key part for Next-Generation sequencing and many efforts
have been made to improve and simplify the process. We developed an easy way
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to prepare NGS library on a solid surface. Poly-acrylamide gel was used to mimic
the Illumina flow cell surface with adaptor sequences imbedded in the gel. Then
Tn5 transposases are used to fragment DNA and link them to the surface by
ligating to the oligonucleotides on the gel. The tagmentation process is similar to
the Nextera kit while our approach has many advantages. First, based on the
sequencing data, the library generated on the surface has less bias than the one
made in solution (Nextera kit), which improves the quality of sequencing library.
Second, we used our home-made Tn5 instead of the commercial one, which
potentially decreases the overall cost of library preparation. Third, preparing the
library on surface would allow one to proceed to cluster generation without
additional PCR amplification and transferring materials. Therefore, the whole
library can be constructed on a flow cell without complicate sample handling, which
would significantly simplify the whole process. Also, we used DNA combing
method to stretch DNA on PDMS and transfer to poly-acrylamide gel surface in
order to increase the capture efficiency of transposases and reduce the amount of
starting material. When combed DNA are used, a good library can be generated
with as little as 50 ng of DNA, which is appropriate for most genomic research.
Library preparation has long been a bottle neck of the development of NGS. With
standard protocol, a library can be prepared in about 10 hours. Though the Nextera
technology brought the total hands-on time to 30 min, the high cost of the kit
prevents it from been widely used. Our surface library construction approach would
allow lower cost and less labor of the whole process as well as high quality of final
library. In the third chapter of the dissertation, the details about the library

109

preparation on surface are provided. An example of library construction using
Drosophila genomic DNA is also described. We will apply our approach to human
genomic DNA and sequence on a more powerful platform (e.g. HiSeq, NovaSeq
etc.) in the future.

The current NGS technologies are of low cost and high accuracy but suffers from
short length of sequencing reads. Though there are many attempts to increase the
read length directly or indirectly, the performances are far from satisfactory. Here
we presented an approach to generate megabase long read with an array-based
technology. First, we synthesized a DNA chip, which has unique oligonucleotide
sequence as barcode indicating its physical location on chip. Then megabase long
genomic DNA molecules are stretched on the chip. After that, DNA molecules are
tagmented to chip by transposases, which is the same procedure as our surface
library construction. Therefore, each DNA fragment is linked to a unique barcode
which makes it trackable after sequencing. With location information provided by
the barcodes, the short fragments can be scaffolded into megabase long synthetic
reads easily. The megabase length is longer than any of the reads created by
current technologies, which would allow comprehensive sequencing for human
genome. With our approach, the sequences in the repetitive regions can be
resolved and the SNPs can be phased and put into scaffolds that each span across
whole chromosome. In addition, complicated structure variants which involve large
DNA fragments can be easily detected. The cost of our method is comparable to
the standard library preparation for Illumina sequencing and no expensive
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equipment nor sophisticated procedures are needed. Only a barcode DNA chip is
required, and the chip can be incorporated to the Illumina flow cell so that library
construction and cluster generation are done on the same surface. Ultimately, no
hands-on work is needed and all the processes run automatically within the
sequencing machine. One can just load DNA sample into the flow cell and let the
machine handle the rest.

Both methods described here use Tn5 and construct library on surface, which
significantly simplified the whole library preparation process. Also, the surface
reaction increases the quality of final library by introducing less bias. Since the
library molecules are fixed on surface, they can be extracted by PCR and reused
for future sequencing instead of prepare library from the very beginning, which will
not only save researchers’ time but also make the experiments more reproducible.
Library preparation on surface provide new insights for the improvement of NGS
technologies and would speed up the development of genomic research. The
megabase sequencing technology, which is based on three fantastic DNA
techniques: DNA chip, DNA combing and surface tagmentation, can generate
super long reads with a relatively simple protocol. This method will allow the
complete sequencing of human genome and contribute to the human genomic
research.
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5.2 Epigenomics
Epigenetics, which focus on the heritable phenotype changes that are not caused
by the change of DNA sequence, is an emerging research area. It usually involves
the modification of specific bases in genome. DNA methylation (5-methylcytosine,
5mC) is the most understood epigenetic modification (164-166). DNA methylation
always occurs in CpG islands of cis-regulatory sites. This modification can be
converted to 5-hydroxymethylcytosine (5hmC), 5-carboxylcytosine (5caC), and 5formylcytosine (5fC) after oxidization while the function of these modifications
remains unclear (167-169). The extra methyl group at the 5’ position of the cytosine
residue can affect the gene expression by altering chromatin structure. In most
cases, the methylation modification in gene promoters lead to transcriptional
repression (170-176). DNA methylation is also involved in many biological
processes such as stem cell differentiation, genomic imprinting and inflammation,
which play a critical role in both physiologic and pathologic conditions (177).
Therefore, it is important to uncover the DNA methylation patterns so as to answer
biological questions and contribute to translational research (178,179).

Bisulfite sequencing (BS-Seq) is the golden standard for DNA methylation
detection (180,181). Basically, the unmethylated cytosine can be converted to
uracil after bisulfite treatment while the methylated cytosine remains unaffected.
Therefore, after library preparation and sequencing, the methylated spots can be
decided by comparing the sequencing reads to the reference genome. This
method would allow single base resolution detection of DNA methylation and
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together with the current NGS technologies, DNA methylation patterns can be
captured across the whole genome (182). However, it is difficult to align the
bisulfite treated sequences to the reference genome because of the base alteration
(183). To solve this problem, one has to sequence the library with higher than
normal depth of coverage, which leads to the increasing of overall cost. Rather
than doing the bisulfite conversion, PacBio and Oxford nanopore technologies can
detect DNA methylation directly (40,184-186). Once a modified base is sequenced
on these platform, it usually generates a different signal that can be captured by
the sequencers. Therefore, with these third-generation sequencing (TGS)
technologies, both DNA sequences and epigenetic modifications can be decided
at the same time. However, the TGS technologies suffer from high cost and low
accuracy, which prevent them being widely used for methylation detection.

In our lab, we developed a method called methyl-combing (a detailed protocol is
provided in the end of this dissertation) to detect DNA methylation. First, we stretch
genomic DNA on surface and fix them by crosslinking. Then the methylated bases
are labeled with fluorescent antibodies. Finally, we visualize these DNA molecules
under super resolution microscope, which can allow single base resolution with the
help of some computational algorithm. By using methyl-combing, we can actually
see the big picture of DNA methylation patterns across the whole genome without
DNA sequencing. However, the downstream image process may be challenging
because of the false positive signals. In the future, we can combine our method
with bisulfite sequencing to detect DNA methylation. First, we decide the
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methylation area (where there is a high volume of DNA methylation) by methylcombing and then analyze the methylation patterns by BS-Seq on targeted areas.
In this way, not only the whole genome methylation patterns can be captured, but
the overall cost is decreased.

Figure 31. Methyl-combing.
(a) Methylation sites detection with specific antibody. The YoYo-stained DNA
molecules are first stretched on surface. Then denature the DNA with NaOH to
allow primary antibody binding. Finally, label the sites with fluorescent conjugated
secondary antibody. (b) Cy-3 labeled DNA under microscope. Combed DNA
molecules are stained with YoYo-1 dye (green) and the methylation sites are
marked by Cy-3 (red).

There are people using tagmentation to prepare libraries for BS-Seq in order to
reduce the cost. Masako Suzuki et al. developed an approach called BS-tagging,
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by which they used methylated dCTPs to fill the end after tagmentation (187). Then
only one strand can be amplified after bisulfite treatment as adaptor sequences
remain the same with the protection of methylation. Therefore, the final library is
simplified by remove the duplicates while still keep the same level of complexity.
Dieter Weichenhan’s group also used transposases for BS-Seq (188). They can
generate a library for BS-Seq with as little as 20 ng of DNA, which is big
improvement and advantage especially when only a limited amount of DNA is
available. With the megabase sequencing technology, we can further decrease the
overall cost by simplifying the library preparation procedure. Also, the megabase
long reads with high accuracy would allow easy reads alignment without increasing
the depth of sequencing. It should be possible to incorporate our methyl-combing,
megabase sequencing with BS-Seq to increase the accuracy of DNA methylation
detection and obtain comprehensive epigenetic information with reasonable cost.

5.3 RNA-Seq
Phenotype is mostly decided by genotype. According to the central dogma of
molecular biology, all the genetic information is originally stored in DNA. Then it
goes into RNA after transcription. Finally, the information expresses as proteins by
translation, which characterize one’s phenotype together with environmental
factors (189). Generally, a cell’s type and biological function are determined by the
RNA molecules it contains. Therefore, it is critical to study the RNA molecules so
as to understand specific functions of a genome and their role in development and
various diseases. And sequencing is the most straightforward way to interpret the
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genetic information in RNA molecules. There are two categories of RNA, proteincoding RNA and non-coding RNA. Most of the biological research focus on the
protein-coding RNAs as their function can be analyzed by studying the protein
products. However, the non-coding RNAs also play important roles during the flow
of genetic information (190,191). For example, microRNA (miRNA) and piwiinteracting RNA (piRNA) can affect gene expression during or after transcription
process. Recent studies also shown that long non-coding RNAs (lncRNAs) have
multiple functions that regulate gene expression, which include transcriptional
control and chromatin remodeling (192-195).

As speaking of RNA sequencing, one means to obtain the sequence of mRNA.
The general workflow of RNA sequencing on NGS platforms contains two parts:
RNA isolation and library construction (196). First, all the RNA molecules are
extracted from the sample and mRNAs are selected by their poly-A tail, which can
be captured by poly-T oligos that are linked to magnetic beads. Then the mRNAs
are reverse-transcribed into cDNA and double stranded. The following steps would
be the same as DNA library preparation: fragment, end-repair, ligate adaptors and
PCR amplification. Finally, the library is sequenced and the data is used for
transcriptome assembly, RNA splicing and gene expression analysis. The major
sequencing platform for RNA sequencing is still NGS sequencer provided by
Illumina for its high throughput, low error rates and overall cost. Despite the bias
induced by PCR amplification, proper PCR controls and downstream
computational analysis may diminish this affect. Alternatively, third generation
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sequencing platforms can be used, which do not require PCR amplification during
library preparation. Besides, these sequencers can generate very long reads (~10
kb), which is good for large transcriptome assembly and also improves the
efficiency of novel transcript detection (197,198). However, the biggest
disadvantage of TGS platforms is the poor sequencing accuracy. The error rate
for PacBio sequencer is ~ 5% (199) and it’s even worse for ONT sequencer. The
reads with low accuracy needs to be fixed by complicated computational algorithm
before they can align to the reference genome and be used for downstream data
analysis.

Our megabase sequencing technology can be used for RNA sequencing library
construction and provide higher than standard quality of sequencing data. We can
generate super long reads with high accuracy, which is suitable for RNA
sequencing data analysis. Since RT-PCR is not good at producing long cDNA, we
can stretch long mRNA on surface and tagment them on barcode chip followed by
RT-PCR so as to get full length of cDNA. As there is a poly-A tail for mRNA
molecules, we can design the poly-T sequence on the chip to link the mRNA
instead of using transposases. And do the reverse transcription directly on chip
surface to produce cDNA. Moreover, a tissue slice can be applied to the chip and
all the mRNAs can be captured by oligonucleotides on chip after permeabilization.
Therefore, we can obtain spatial gene expression information after sequencing.
Besides, there is no RNA isolation needed, which simplify the whole process.
Alternatively, the reverse-transcribed cDNA can be combed and load onto chip for
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surface tagmentation and library construction. With the barcode information
provided by the chip, short sequencing reads can be scaffolded into very long
synthetic reads and contribute to the transcriptome assembly and RNA splicing
analysis.

5.4 Genomic medicine
Human Genome Project was started in 1990 with the hope to fully understand the
human genome and apply to general practice of medicine. Today, 15 years after
the completion of the project, DNA sequencing has been widely used in healthrelated research and is on its way to be a routine for clinical care. Along with that,
genomic medicine as a new technical term is becoming more and more popular.
According to NHGRI, genomic medicine is an emerging medical discipline that
involves using genomic information about an individual as part of their clinical care
and the health outcomes and policy implications of that clinical use.

Genomic medicine is making impacts in the diagnosis and treatment of various
diseases (200-206). For some rare diseases, there is no routine diagnosis
procedure and it is challenging to figure out what could be wrong while genome
sequencing can help. For example, a team from Netherlands conducted DNA
sequencing across several hundreds of intellectual disabled children together with
their unaffected parents in order to find novel candidate genes and mutations that
involved in this disease (207). Instead of using traditional ultrasound and blood test,
DNA sequencing serve as a new approach for noninvasive prenatal testing. Fetal
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DNA that released into mother’s blood can be sequenced and potential health
problems can be picked up. A whole genome sequencing for newborns can screen
for a large number of diseases simultaneously (208). Genomic medicine has
already changed the way for certain cancer diagnosis and treatment. The cause
of cancer can be very complicated and usually involves multiple mutations, which
makes it difficult to diagnose with traditional methods while genome sequencing
may provide a clue. Only certain portion of colorectal cancer patients can benefit
from aspirin treatment and people didn’t know why until a mutation was uncovered
by DNA sequencing. There are approximately 20% colorectal cancer patients that
have a PIK3CA mutation respond well to aspirin treatment and are also associated
with increased survival compared to the patients who do not have this mutation
(209). Recently, researchers found cell-free circulating DNA (cfcDNA) in cancer
patients (210-216). These DNA fragments are released into bloodstream after the
death of tumor cells. Therefore, the cfcDNA can be used for early stage cancer
detection and also be used to monitor tumor progression. Pharmacogenomics,
which is part of genomic medicine, gets more and more attention. The core of
pharmacogenomics is to choose the correct therapy based on one’s genome
information. FDA has already approved more than 100 drugs that have
pharmacogenomics information in their labels and 45 human genetic tests are
cleared or approved by FDA (https://www.genome.gov/). With the development of
novel sequencing technologies, the diagnosis and treatment for more and more
diseases will be genomic based. And genomic medicine is going to transform the
traditional medicine.
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Despite the importance of whole genome information for genomic medicine,
comprehensive human genome sequencing remains challenging for the current
technologies. The short-read method can sequence the genome with high
throughput and low cost but fail to resolve large repetitive regions which leave
many gaps. The long-read approach can generate long reads to fill the gaps but
suffer from low throughput and high error rates. The technologies I described in
this dissertation may be a good solution to take advantages from both short-read
and long-read methods while avoid all the drawbacks. The megabase long
accurate reads produced by our approach has the potential to uncover 100% of
human genome. With the complete human genome information, the genetic
analysis for diseases would be more comprehensive and more accurate. Besides,
our technologies can be incorporated into current sequencers with only minor
adjustments. Once the whole process is automation-enabled, it would be a
dramatic improvement for genetic test. With the complete genome information and
the following data report, physicians would need minimal training to interpret the
sequencing results and uncover what could be wrong with the patient and come
up with the corresponding plan for the treatment.
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APPENDICES

Appendix A Protocol --- Tn5 expression and purification
1. Thaw Tn5 plasmid and C3013 competent cells on ice for 3~5 min
2. Take a new 1.5 ml tube and transfer 20 µl competent cells into it, then add 1 µl
of Tn5 plasmid, mix by tapping and incubate on ice for 30 min
3. Heat shock for 45 s at 42°C, then put it back on ice for 5 min
4. Add 250 µl of LB media (without Amp+) to the tube and transfer to a 15 ml
bacteria culture tube, incubate on a shaker for 1h at 37°C
5. Spread the culture onto a LB plate (contains Amp+) and incubate at 37°C
overnight
6. Pick 10 colonies and grow in 5 ml LB media (Amp+) for 4~5 h. Transfer to 250
ml LB media and grow until OD600 goes to 0.75~1
7. Add IPTG to 0.25 mM (62.5 µl of 1 M IPTG) and chill the culture to 10°C,
continue grow for 4 hours at 23°C
8. Harvest cells by centrifuge at 6,000xg, 15 min, 4°C, frozen the pellet at -80°C
overnight
9. Prepare the chitin column:
a. Equilibrate column, chitin resin, and column buffer to room temperature
b. Secure a bottom cap on the column tip, add column buffer to fill it up to the
reservoir portion. Then gently tap the end and side of the column to dislodge any
air bubbles
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c. Float a porous disc on top of the liquid within the column, push the disc evenly
to the bottom of the column
d. Add 5 ml of chitin resin to the column and allow gel to settle in the column for
at least 30 min
e. Put a second porous disc on top of the settled gel bed and push down to just
above the settled gel. Leave 1-2 mm of space between the top of the gel bed and
the top disc. Do not compress the gel bed!
f. Wash the column with 10 volume of column buffer
g. Store the packed column upright at 4°C with gel bed submerged under 1-2
ml column buffer
10. Add 20 ml HEGX to the pellet and mix thoroughly by pipetting and vertexing.
Sonicate on ice for 10 cycles, 15 s for each cycle at output 6, 25% duty
11. Pellet the lysate at 15,000 rpm for 30 min at 4°C, transfer the supernatants to
a new bottle
12. Add 2.1 ml 10% neutralized PEI dropwisely on a magnetic stirrer.
13. Remove the precipitate by centrifuge at 12,000 rpm for 10 min at 4°C
14. Load the supernatant on a 5 ml chitin column. 7 ml at a time and incubate for
15 min.
15. Wash the column at 0.2 ml/min with 100 ml HEGX.
16. Add 14 ml HEGX and 100 mM DTT (7 ml 2x HEGX, 1.4 ml 1M DTT, 5.6 ml H20
to final 14 ml) to the top of the column bed. After 7ml buffer drained out of the
column, keep the column closed for 36-48 h at 4°C
17. Collect 14 fractions, 20 drops per fraction
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Column regeneration: wash with 3 bed volumes of stripping buffer. Allow the resin
to soak for 30 min and then wash with an additional 7 bed volumes of stripping
buffer. Rinse with 20 bed volumes of water followed by 5 bed volumes of column
buffer. The resin can be stored at 4°C. For long term storage 0.02% sodium azide
should be added to the column buffer.

18. Run 25 µl of each fraction on SDS-PAGE.
19. Coomassie Staining:
Staining buffer: 0.2% coomassie, 50% methanol, 10% acetic acid
Destaining buffer: 40% methanol, 10% acetic acid
a. Rinse the gel with water once.
b. Add staining buffer and put in the microwave oven heat for 8 s twice
c. Gentle rock on a shaker for 8~10 min
d. Destaining for several times until the band become clear.
e. Store the gel in water at 4°C
Staining buffer can be reuse for 4~5 times
20. Pool the fractions with highest concentration and dialysis versus two changes
of 1 L of 2x Tn5 dialysis buffer.
21. Concentrate the protein: Amicon Ultracel 30, 3000xg 20-25 min periods to a
final OD280 of at least 3.0 (35 µM).
22. If not used directly for transposase assembly add, 1.1 vol 99.5% glycerol and
0.33 vol of 2x Tn5 dialysis buffer (final 55% Glycerol), and store at -20°C.
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23. Prepare MEDS: (prepare A and B separately)
5 µl

1 mM Tn5ME-A/B stock

5 µl

1 mM Tn5MErev

40 µl

1x TE

Mix well and heat up to 98°C for 3 min and cool down to 44°C for 15 min. Store
the MEDS in -20°C
24. Assembly of equimolar MEDS with Tn5 in solution
0.5 vol. 50 µM MEDS (A or B) in TE
1 vol. 80% Glycerol
0.5 vol. 50 µM Tn5 = A280 4.32 = 2.66 mg/ml in 2x Tn5 dialysis buffer
Or
1 vol. 55% glycerol stock
0.143 vol. 100 µM MEDS (A or B) in TE
Mix and keep 60 min at 37°C. After incubation, mix the Tn5A-MEDS and Tn5BMEDS solutions to get 12.5 µM Tn5 complex. Store at -20°C.
25. Prepare the tagmentation reaction mix on ice:
12 µl H2O
2 µl 10x TAPs-MgCl2
4 µl 40% PEG8000 (40% PEG 8000: 4g PEG 8000 + 7.1 ml H2O)
1 µl HMW DNA @ 50 µg/ml
1 µl Tn5 complex @12.5 µM
Incubate at 55°C for 7 min.
26. Clean up tagmentation reactions by using Qiagen column:
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a. Add 5 vol. of buffer PB into the tagmentation reaction and mix well.
b. Load onto the Qiagen column
c. Spin down at 14,000 rpm for 1 min. Discard the flow through
d. Add 700 µl buffer PE.
e. Spin down at 14,000 rpm for 1 min. Discard the flow through
f. Spin again
g. Put the column on a collection tube
h. Add ~20 µl of 1x TE and incubate in room temperature for 2 min
i. Spin down at 14,000 rpm for 1 min.
27. Run the cleaned up on 2% agarose gel
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Appendix B Protocol --- Library preparation on poly-acrylamide gel
1. Prepare salinized slides
a. Add 8.8 µl Acetic Acid to the 40 ml H2O
b. Add 160 µl Bind-Silane and mix for 15 min on a shaker
c. Load slides into Coplin buckets and add mixture prepared above
d. Incubate with slow shaking for 1~24 h at RT
e. Rinse 3 times with dH2O
f. Rinse once with 100% ethanol
g. Let it dry in a PCR hood
h. Transfer slides to storage boxes
2. Prepare fresh "ABD mix" in a 1.5 ml tube:
1000 µL Acrylamide / Bis (19:1; 38%:2%)
20 mg DATD
3. Degassing the ABD mix with 0.22 µm filter
4. Prepare fresh 5% APS (0.05 g APS →1 ml dH20)
5. Prepare fresh 5% TEMED (2 µl TEMED → 38 µl dH20)
6. Prepare the gel-casting mix (50 µl total volume)
5 µl

ABD mix

10 µl

Acrydite modified primers (10 µM)

33 µl

dH20

1 µl

5% TEMED

1 µl

5% APS
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7. Gel Loading: add 5 µl of the mix onto a slide. Put a coverslip (22 x 22 mm) on
top of it and allow gels to polymerize for 1 h at RT
8. Use a razor-blade cleanly remove cover-slips from polymerized gels
9. To wash off the excess acrylamide monomer, place slides in a 0.5x SSC filled
50 ml falcon tube and incubate for 30 min at RT with slow shaking
10. Take the slides out from tube and place face up in PCR hood.
11. Mix 5 µl of Tn5 (55% glycerol stock) with 5 µl of 1xTE and add onto the gel
surface. Put a coverslip on top of it. Incubate at 37°C for 1 h
12. Transfer the slide into 4°C and let it sit for 3 min
13. Wash the slides with Tn5 wash buffer on a shaker for 3~5 min
14. Prepare tagmentation mix:
10x TAPs-MgCl2

1 µl

40% PEG8000

2 µl

dH2O

5 µl

DNA (200 ng/µl)

2 µl

Mix well and load onto the surface. Put a coverslip on top of it. Incubate at 55°C
for 15~30 min
15. Wash the slides with dH2O on a shaker for 3~5 min
16. Scrape off the gel and do PCR as the following protocol:
Prepare the PCR reaction
10 mM dNTP

1 µl

10 µM Forward Primer

0.25 µl

10 µM Reverse Primer

0.25 µl
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10x Standard Taq Buffer
dH2O

5 µl
43.3 µl

Taq polymerase

0.2 µl

PCR program
a. 68°C

3 min

b. 95°C

30 s

c. 95°C

15 s

d. 63°C

30 s

e. 68°C

3 min

go to step c for 15 times
17. Clean up by Qiagen PCR purification kit
a. Add 5 vol. of buffer PB into the tagmentation reaction and mix well.
b. Load onto the Qiagen column
c. Spin down at 14,000 rpm for 1 min. Discard the flow through
d. Add 700 µl buffer PE.
e. Spin down at 14,000 rpm for 1 min. Discard the flow through
f. Spin again
g. Put the column on a collection tube
h. Add ~20 µl of 1x TE and incubate in room temperature for 2 min
i. Spin down at 14,000 rpm for 1 min.
18. Run 10 µl on 2% agarose gel.
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Appendix C Protocol --- Genomic DNA extraction and quantification
1. Resuspend 3x106 cells in 150 µl PBS
2. Add 250 µl warm (37°C) Phenol/chloroform/isoamyl alcohol (PCL) solution
(25:24:1)
3. Mix on a rotator for 10 min at room temperature
4. Centrifuge at Max speed for 10 min at room temperature
5. Transfer the top layer to a new 1.5 ml tube
6. Add 10x volume ice cold 100% ethanol, mix by inverting several times and
incubate at -20°C overnight
7. Centrifuge at Max speed for 30 min at 4°C
8. Remove the supernatants and add 1 ml 80% ice cold ethanol (Don’t disturb the
pellet!)
9. Centrifuge at Max speed for 20 min at 4°C
10. Wash again with 80% ethanol
11. Air dry for 1~2 min
12. Resuspend in 50 µl 1x TE and store at 4°C
13. Quantify the DNA with Qubit dsDNA BR Assay Kit
a. Prepare the working solution by diluting the dsDNA BR Reagent 1:200 in
dsDNA BR Buffer
b. Add 10 µl of each Qubit® standard to 190 µl of working solution, then mix by
vortexing 2–3 s. Be careful not to create bubbles
c. Add 2 µl sample to 198 µl working solution, mix by vortexing 2–3 seconds
d. Incubate at room temperature for 2 min.
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e. Load the tubes on a Qubit® 2.0 Fluorometer and read for the concentration
14. Store the extracted genomic DNA at -20°C
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Appendix D Protocol --- Library purification and size-selection with AMPure
beads
1. Add the 0.9x volume of AMPure® XP beads to the final PCR solution
2. Pipet up and down 5 times to thoroughly mix the bead suspension with the DNA,
then pulse-spin and incubate the mixture for 10 min at room temperature
3. Place the tube in a magnetic rack until the solution is clear. Carefully remove
the supernatant without disturbing the pellet
4. Add 500 µl of freshly prepared 70% ethanol. Incubate for 30 s, turning the tube
around twice in the magnet to move the beads around. After the solution clears,
remove the supernatant without disturbing the pellet
5. Repeat step 4 for a second wash
6. To remove residual ethanol, pulse-spin the tube, place it back in the magnetic
rack, and carefully remove any remaining supernatant
7. Keeping the tube on the magnet, air-dry the beads at RT for 2 min.
8. Remove the tube from the magnetic rack and add 20 µl of Low TE directly to the
pellet to disperse the beads. Pipet the mixture up and down 5 times, then vortex
the sample for 10 s, to mix thoroughly.
9. Pulse-spin and place the tube in the magnetic rack until the solution clears.
Transfer the supernatant to a new 1.5-ml tube
10. The purified DNA can be stored at 4°C or proceed with library QC procedure
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Appendix E Protocol --- DNA combing on PDMS
1. Take a clean 10 cm petri dish, add 2 ml of PDMS monomer and 0.2 ml curing
agent, mix well and incubate at 55°C overnight
2. Take a clean 1.5 ml tube, transfer 1ug of genomic DNA and then add 100 µl of
phosphate buffer (pH7.2), Do Not try to mix by pipetting!
3. Dilute 1 µl of YoYo dye with 300 µl of phosphate buffer (pH7.2)
4. Add 100 µl of diluted YoYo dye to the above prepared DNA solution, stain the
DNA at 4°C overnight
5. Take 50 µl of YoYo stained DNA and add into a reservoir contains 1 ml of
phosphate buffer
6. Attach a slice of PDMS on a coverslip and load onto a stretching machine.
7. Dip the PDMS into reservoir and let it sit for 1 h
8. Pull it up at the speed of 300 µm/s
9. Visualize the combed DNA with a fluorescent microscope or transfer the combed
DNA to poly-acrylamide gel by bring the two surfaces together and press for 3 min
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Appendix F Protocol --- MiSeq sequencing
1. prepare fresh Library Dilution Buffer
10 mM Tris-Cl, pH 8.5
0.1% Tween 20
2. Remove the tube of HT1 (Hybridization Buffer) from -15°to -25°C storage and
set aside at room temperature to thaw.
3. Place the reagent cartridge in a water bath containing enough room temperature
deionized water to submerge the base of the reagent cartridge up to the water line
printed on the reagent cartridge. Do not allow the water to exceed the maximum
water line. (30 min~1 h)
4. Prepare 0.1 M NaOH
10 µl of 10 M NaOH and 990 µl of NF water
5. Dilute PhiX to 2 nM
Add 2 µl of PhiX (10 nM) to 8 µl of Library Dilution Buffer
6. Dilute sample to 2nM
Add 8 µl sample (4 nM) to 8 µl of Library Dilution Buffer
7. Denature sample and PhiX
Add 10 µl of 0.1 M NaOH to 10 µl of 2 nM sample
Add 10 µl of 0.1 M NaOH to 10 µl of 2 nM PhiX
Incubate for 5 min @RT
8. Dilute denatured sample to 20 pM
Add 980 µl of pre-chilled HT1 to 20 µl of sample
Add 980 µl of pre-chilled HT1 to 20 µl of PhiX
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9. Dilute denatured sample to 13~13.5 pM
13 pM
95% sample

617.5 µl

5% PhiX

32.5 µl

HT1

350 µl

13.5 pM
95% sample
5% PhiX
HT1

641.25 µl
33.75 µl
325 µl

10. Keep the sample on ice while preparing the flow cell and reagent cartridge
11. Invert the reagent cartridge ten times to mix the thawed reagents, and then
visually inspect that all positions are thawed
12. Visually inspect the reagent in position 1 to make sure that it is fully mixed and
free of precipitates
13. Clean the flow cell and clean with MiliQ water, then ethanol swab, finally with
lens paper
14. Load the flow cell into the sequencer
15. Change the name of the sample sheet accordingly
16. Open the sample well with a tip and add 800 µl of Library to Reagent Cartridge
17. Follow the guide on sequencer
18. After 5 mins pre-checks, press Start Run
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Appendix G Protocol --- Library preparation on barcode chip
1. Block the surface with 100 µl 0.2 mg/ml BSA in wash buffer for 20 min at 37°C
2. Wash twice with wash buffer
3. Add 0.5 µl of pre-loaded Tn5 and incubate at RT for 30 min
4. Wash twice with wash buffer
5. Add 100 ng DNA in 100 µl working buffer and incubate for 10 min at 37°C
6. Add 11 µl 10x TAPs buffer, incubate at 55°C for 20 min.
7. Add 12 µl 5% SDS and incubate at 37°C for 10 min
8. Wash twice with wash buffer
9. Prepare the gap filling mix on ice
10x E. coli ligase buffer

10 µl

1 mM dNTP mix

1 µl

BSA (10 mg/ml)

1 µl

T4 polymerase

1 µl

E. coli ligase

1 µl

NF water

86 µl

Add the mix to the chip and incubate at 37°C for 30 min
10. Inactivate enzymes for 20 min at 75°C
11. Wash twice with wash buffer
12. Rinse twice with 0.2 M NaOH
13. Prepare the Klenow extension mix on ice
10x Extension buffer
10 mM dNTP mix

10 µl
2 µl

135

100 µM short primer

2 µl

Klenow (exo-)

1 µl

NF water

85 µl

Add the mix to the chip and incubate at 37°C for 1 h
14. Wash twice with wash buffer
15. PCR for 21 cycles
PCR reagents setup
10 mM dNTP

2 µl

10 µM Primer Mix

1 µl

10x Buffer

10 µl

water

86.5 µl

Taq polymerase

0.5 µl

PCR program
a. 98°C

30 s

b. 98°C

10 s

c. 63°C

30 s

d. 72°C

1 min

go to step b for 20 times
16. Clean up with Qiagen column
a. Add 5 vol. of buffer PB into the tagmentation reaction and mix well.
b. Load onto the Qiagen column
c. Spin down at 14,000 rpm for 1 min. Discard the flow through
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d. Add 700 µl buffer PE.
e. Spin down at 14,000 rpm for 1 min. Discard the flow through
f. Spin again
g. Put the column on a collection tube
h. Add ~20 µl of 1x TE and incubate in room temperature for 2min
i. Spin down at 14,000 rpm for 1 min.
17. Quantify the library with Qubit and store at 4°C
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Appendix H Protocol --- Extract long DNA molecules from cells
1. Prepare a cell suspension in isotonic saline or tissue culture medium without
fetal bovine serum. (~ 1 million)
2. Melt 370 µl 2% CleanCut agarose solution using a microware and equilibrate
the solution to 50°C in a water bath.
3. Centrifuge the cell suspension at 1,000 x g for 5 min at 4°C. Resuspend the
cells in the 630 µl of Cell Suspension Buffer and equilibrate the cell suspension to
50°C.
4. Combine the 2% CleanCut agarose with the cell suspension and mix gently, but
thoroughly. Keep the cell/agarose mixture at 50°C.
5. Transfer the mixture to plug molds (100 µl/plug) and allow the agarose to solidify.
This step can be expedited by placing the molds at 4°C for 10-15 min.
6. Use a 15 ml centrifuge tube, add 100 µl of Proteinase K stock to 2.5 ml of
Proteinase K Reaction Buffer.
7. Push the solidified agarose plugs into that 15 ml tube contain diluted Proteinase
K. Incubate the plugs overnight at 50°C without agitation.
8. Wash the plugs four times in 1 ml 1x Wash Buffer, 1 h each at room temperature
with gentle agitation.
9. Store the plugs at 4°C in 1x Wash Buffer. The plugs should be stable for 3
months.
10. Wash the plug to be dissolved 3 times in 1ml 1x TE (10 min each time) at room
temperature.
11. Remove the plug from TE with spatula, try to remove all traces of TE.
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12. Transfer to 400 µl 100 mM MES solution pH6.5, in a round bottom 2 ml cryo
tube.
13. Melt at 70°C for 20 min.
14. Equilibrate to 42°C a few minutes.
15. Directly add 2 µl β-agarose enzyme. Don’t try to mix! Incubate overnight at
42°C.
16. Fill on third of a Teflon reservoir with 500 mM MES pH5.5.
17. Pour DNA into reservoir (Do not Pipette!)
18. Gently add additional 500 mM MES pH5.5 up to the top.
19. Cover the reservoir with parafilm so it doesn’t dry out, place in dark at RT
20. Let DNA sit for a day of two before stretching
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Appendix I Protocol --- Hi-C for SK-BR-3 cells
Cell crosslinking
1. Aspirate the medium and wash 2 times with PBS, then add 10 ml of fresh
medium (37°C) without serum per T75 flask.
2. Crosslink the cells by adding 278 µl of 37% formaldehyde to obtain 1% final
concentration. Mix gently, immediately after addition of formaldehyde.
3. Incubate at room temperature (RT) for exactly 10 min. Gently rock the plates
every 2 min.
4. To quench the crosslinking reaction, add 556 µl 2.5 M ice cold glycine, mix well.
5. Incubate for 5 min at RT and then incubate on ice for at least 15 min to stop
crosslinking completely.
6. Scrape the cells from the plates with a cell scraper and transfer to a 15 ml tube.
7. Centrifuge the crosslinked cells at 800xg for 10 min, 4°C.
8. Discard the supernatant by aspiration. It is important to remove the liquid phase
completely.
9. Wash once with 1 ml cold PBS and transfer to a 1.5 ml tube.
10. Cells can be snap-frozen in liquid nitrogen and stored at -20°C for at least 1
month or one can continue with cell lysis.

Cell lysis and chromatin digestion
1. Wash cells once with 1 ml cold PBS, centrifuge for 5 min at 2,000xg RT.
2. Resuspend crosslinked cells in 550 µl of ice-cold lysis buffer containing 50 µl
protease inhibitor cocktail.
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3. Incubate for 30 min on a rotator at 4°C.
4. Centrifuge for 5 min at 2,000xg at RT.
5. Discard the supernatant and then wash the pellet twice by resuspending it in
500 µl of ice cold 1x NEBuffer 2 and then centrifuging the sample for 5 min at
2,000xg.
6. Resuspend the pellet in 260 µl 1x NEBuffer 2.
7. Distribute the cells between 5 individual 1.5 ml centrifuge tubes (50 µl per tube).
(Optional) Chromatin integrity control.
a. Take 10 µl of lysed cells from the previous step. Add 50 µl of 1x NEBuffer 2 and
2 µl of Proteinase K (10 mg/ml). Incubate for 30 min at 65°C.
b. Purify DNA by single phenol-chloroform extraction without ethanol precipitation
(add one volume phenol-chloroform and vortex 30s, then spin at 14,500 rpm, 5
min).
c. Add 2 µl of RNAseA (10 mg/ml) to the aqueous phase @37°C 15 min.
d. Check quality of the sample by running it on 0.8 % agarose gel (120 V, 30 min).
The sample is good if DNA is either stuck in the well or runs as a single high
molecular weight band (>23 kb).

8. Add 312 µl of 1x NEBuffer 2 to each tube.
9. Add 38 µl of 1% SDS (newly made) to each tube. Mix carefully by pipetting.
10. Incubate at 65°C for 10 min exactly and then place tubes on ice immediately.
11. Add 44 µl of 10% Triton X-100 to each tube to quench the SDS. Mix gently by
pipetting up and down. Avoid making bubbles.
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12. Add 5 µl BSA (100x) and 400 Units (4 µl) of HindIII to each tube, mix gently.
13. Digest the chromatin overnight at 37°C on a rotator.
14. Take 10~30 µl from each tube and check the digestion efficiency. Purify DNA
as step 7. Run it on the 0.8% agarose gel. A successful digestion results in a DNA
smear with the majority of fragments located between 5 and 10 Kb.

Marking ends and Ligation
1. Spin the tubes briefly at 2,500xg and put on ice. Keep one tube separate to
serve as a 3C control for the biotin incorporation control.
2. Prepare the Biotin Fill-in master-mix as follows:
Fill-in mix (add in this order)
Water
10x NEBuffer 2

Per reaction
16.0 µl
6.0 µl

10 mM dATP

1 µl

10 mM dGTP

1 µl

10 mM dTTP

1 µl

0.4 mM biotin-14-dCTP
5U/ µl Klenow

25 µl
10.0 µl

3. Add 60 µl of the Fill-in master-mix to each Hi-C tube and 60 µl of water to the
3C tube. Mix gently by pipetting up and down.
4. Incubate the tubes at 37°C in a water bath for 75 min. Invert the tubes every 10
~ 15 min.
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5. Place the tubes on ice immediately. Then add 86 µl of 10% SDS to all the tubes
and mix carefully.
6. Incubate tubes at 65°C for 30 min exactly and place on ice immediately
afterwards.
7. While incubating tubes at 65°C, prepare the ligation mix as follows on ice:
Ligation mix
Water

Per reaction
6,030 µl

10x ligation buffer

745 µl

10% Triton X-100

745 µl

10 mg/ml BSA

80 µl

100 mM ATP

10 µl

8. Transfer each sample with digested chromatin to a corresponding 15 ml tube.
9. Add 1 µl of 400 U/µl T4 DNA ligase to each tube and mix well by inverting the
tubes.
10. Incubate all 5 tubes at 16°C overnight.

Reverse crosslinking and DNA purification
1. Add 30 µl of 10 mg/ml proteinase K and incubate at 65°C for 4 hours.
2. Add another 30 µl of proteinase K and continue incubating at 65°C overnight.
3. Cool the reaction mixtures to room temperature and transfer to 50 ml tubes.
4. Extract the DNA twice by adding one volumes of phenol pH8.0:chloroform to
each tube, vortex for 30 s, spin at 3000xg for 10 min.
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5. Carefully transfer as much of the aqueous phase as possible (~7.5 ml) to a new
50 ml tube suitable for spinning at high speed.
6. Add 1/10 volume of 3M sodium acetate, pH5.2, vortex briefly.
7. Add 2~2.5 volume of ice-cold 100% ethanol and mix well by inverting.
8. Incubate for ~1 h at -80°C until the sample becomes viscous but not solid.
9. Centrifuge for 30 min at 18000xg, 4°C.
10. Decant the supernatant with extra caution as the pellet detaches from the tube
wall quite easily.
11. Air dry the DNA pellets very briefly (~1 min) and resuspend the pellets in 400
µl 1x TE. Transfer the DNA mixture to a 1.5 ml tube.
12. Add 500 µl phenol pH8.0: chloroform and vortex for 30 s. Centrifuge for 5 min
at 14500 rpm and transfer the aqueous phase to a new tube. Then extract again.
13. Add 1/10 volume of 3 M sodium acetate, pH5.2, vortex briefly.
14. Add 2 volumes of ice-cold 100% ethanol and mix well by inverting the tubes.
15. Incubate for about 30 min at -80°C.
16. Centrifuge for 20 min at 14000 rpm, 4°C.
17. Resuspend DNA in 50~100 µl 1xTE and add 2 µl 1 mg/ml RNase A, incubate
for 30 min at 37°C.
18. DNA samples can be stored at -20°C.

Removal of Biotin from un-ligated ends
1. Set up several reactions as follows:
Hi-C DNA sample

5 µg
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10x NEBuffer2.1

5 µl

2.5 mM dATP

0.5 µl

2.5 mM dGTP

0.5 µl

T4 DNA polymerase
Water

5 µl
to 50 µl

2. Incubate at 20°C for 4 hours.
3. Add 2 µl of 0.5 M EDTA, pH8.0 to stop the reaction.
4. Pool the reactions together in a 1.5 ml centrifuge tube and bring volume to 450
µl.
5. Purify the DNA with a single phenol: chloroform extraction. (Add 1 volume
phenol: chloroform and vortex 30 s, spin at 14500 rpm for 5 min).
6. Transfer the aqueous phase to a new tube and add 1/10 volume of 3 M sodium
acetate, pH5.2, and vortex briefly to mix.
7. Add 2 volumes of ice cold 100% ethanol, mix by inverting the tube several times.
8. Incubate at -80 °C for 30 min.
9. Centrifuge for 20 min at 14000xg, 4 °C.
10. Air dry the pellet quickly and resuspend in 30~100 µl water.
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Appendix J Protocol --- Sequencing data analysis
First, convert the output file from sequencer to Fastq file with Illumina’s bcl2fastq
tool. The detailed code is as follows:

$ /usr/local/bin/configureBclToFastq.pl \
--input-dir <BaseCalls dir> \
--output-dir <Unaligned> \
--sample-sheet <BaseCalls dir>/bcl2fastq_SampleSheet2.csv \
--no-eamss \
--force \
--ignore-missing-stats \
--ignore-missing-bcl \
--ignore-missing-control \
--fastq-cluster-count 60000000 \
--use-bases-mask y151, y151 \
--mismatches 0

$ cd Unaligned

$ make -j 8

Next, map all the reads to the reference genome with Burrows-Wheeler Aligner
(version 0.7.15) and then output as bam file with SAMtools (version 1.3.1)
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$ bwa mem -t 4 <Reference> <fastq.1> <fastq.2> | samtools view -bS - >
output.bam

Sort and index the bam file
$ samtools sort output.bam output.sorted
$ samtools index output.sorted.bam

Remove the duplicate reads with Picard tools
$ picard-tools MarkDuplicates \
M=dup_reads \
I=output.sorted.bam \
O=output.sorted.dedup.bam
Analyze the breadth and depth of coverage with bedtools and SAMtools

$ bedtools genomecov -ibam output.sorted.bam -g $REF > output.coverage.bed;
$ awk '$2==0' output.coverage.bed | column -t >> stats.txt
$ samtools view -H output.sorted.bam | \
grep -P '^@SQ' | \
cut -f 3 -d ':' | \
awk '{sum+=$1}END{print “Total length of genome is",sum,"bp"}' >> stats.txt
$ samtools depth output.sorted.bam | \
awk '{sum+=$3} END {print "Total sequenced bases is", sum}' >> stats.txt
The depth of coverage = Total sequenced bases / Total length of genome
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Download sequencing data from NCBI Sequence Read Archive (SRA;
http://www.ncbi.nlm.nih.gov/sra) under accession number ERR481289
$ wget ftp://ftp-trace.ncbi.nih.gov/sra/.../sample.sra
$ fastq-dump --split-3 sample.sra
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Appendix K Protocol --- Detect DNA methylation on combed DNA
1. Prepare PDMS: Mix curing agent and PDMS monomers at a 1:10 ratio in a 10
cm petri dish, then incubate at 55°C overnight
2. Stain DNA with YoYo-1: Add 66 µl YoYo stain solution (1 µl YoYo in 1 ml 0.1 M
MES) to 50 ng DNA and bring the volume to 100 µl with 0.1 M MES (pH 5.5).
Incubate overnight at 4ºC
3. Prepare poly-D-lysine coated slides: Incubate clean slides in poly-D-lysine
solution (1 µg/ml) overnight and wash several times with ddH2O
4. Stretch 50 µl YoYo stained DNA on PDMS by rolling drop
5. Transfer combed DNA from PDMS to poly-D-lysine coated slides by pressing
the two surfaces together for 5 min
6. Denature the combed DNA by adding 100 µl of 1 M NaOH and incubate in a
humidified chamber for 3 min at room temperature
7. Wash once with 500 µl PBS and let it dry for 2~3 min at RT
8. Add 100 µl primary antibody (1 µl in 100 µl BlockAid). Place in a humidified
chamber and incubate in dark for 1 h at 37ºC
9. Remove the remaining antibody buffer on the coverslip
10. Add 100 µl of Cy3-conjugated antibody (100 µl of BlockAid, 2.5 µl YoYo stain
solution and 1 µl Goat-anti-Mouse Cy3 antibody.). Place in humidified chamber
and incubate in dark for 1 h at RT
11. Wash once with 500 µl wash buffer (2xSSC, 1% Tween 20). Then add 100 µl
wash buffer, place in humidified chamber and incubate in dark at RT for 5 min
12. Wash again with 100 µl wash buffer
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13. Dry the slide for 5 min in dark at RT
14. Visualize under a fluorescent microscope
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Appendix L Protocol --- Chip printing
1. Prepare salinized slides
a. Add 8.8 µl Acetic Acid to the 40 ml H2O
b. Add 160 µl Bind-Silane and mix for 15 min on a shaker
c. Load slides into Coplin buckets and add mixture prepared above
d. Incubate with slow shaking for 1~24 h at RT
e. Rinse 3 times with dH2O
f. Rinse once with 100% ethanol
g. Let it dry in a PCR hood
h. Transfer slides to storage boxes
2. Prepare 6% acrylamide in a 1.5 ml tube:
15 µl

40% Acrylamide / Bis (29:1)

1 µl

100 µM acrydite oligo

84 µl

water

3. Degassing the above mix with 0.22 µm filter
4. Prepare fresh 5% APS (0.05 g APS →1 ml dH20)
5. Prepare fresh 5% TEMED (2 µl TEMED → 38 µl dH20)
6. Prepare the gel-casting mix (10 µl total volume).
9 µl

6% acrylamide gel

0.5 µl

5% TEMED

0.5 µl

5% APS

7. Gel Loading: 10 µl onto slides. Put a coverslip on top of it and allow gels to
polymerize for 30 min at RT
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8. Use a razor-blade cleanly remove cover-slips from polymerized gels
9. To wash off the excess acrylamide monomer, place slides in a water filled 50 ml
falcon tube and incubate for 2 min at RT with slow shaking
10. Remove slides from tube and place face up in PCR hood.
11. Prepare print solution (100 µl/print)
NF water
BSA (20 µg/µl)
10x ThermoPol buffer

83 µl
1 µl
10 µl

dNTP (10 mM)

2 µl

Bst 2.0 (8U/µl)

4 µl

12. Make ‘’printing sandwich’’ and incubate at 55°C for 3 h
13. Boiling for 15 min at 95°C and store the slides in a desiccator
14. Rehydrate the gel before use
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Appendix M Protocol --- Make pre-loaded Tn5
1. Thaw Tn5 plasmid and C3013 competent cells on ice for 3~5 min
2. Take a new 1.5 ml tube and transfer 20 µl competent cells into it, then add 1ul
of Tn5 plasmid, mix by tapping and incubate on ice for 30 min
3. Heat shock for 45 s at 42°C, then put it back on ice for 5 min
4. Add 250 µl of LB media (without Amp+) to the tube and transfer to a 15 ml
bacteria culture tube, incubate on a shaker for 1 h at 37°C
5. Spread the culture onto a LB plate (contains Amp+) and incubate at 37°C
overnight
6. Pick 10 colonies and grow in 5 ml LB media (Amp+) for 4~5 h. Transfer to 250
ml LB media and grow until OD600 goes to 0.75~1
7. Add IPTG to 0.25 mM (62.5 µl of 1 M IPTG) and chill the culture to 10°C,
continue grow for 4 h at 23°C
8. Harvest cells by centrifuge at 6,000xg, 15 min, 4°C, frozen the pellet at -80°C
overnight
9. Prepare the chitin column:
a. Equilibrate column, chitin resin, and column buffer to room temperature
b. Secure a bottom cap on the column tip, add column buffer to fill it up to the
reservoir portion. Then gently tap the end and side of the column to dislodge any
air bubbles
c. Float a porous disc on top of the liquid within the column, push the disc evenly
to the bottom of the column
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d. Add 5 ml of chitin resin to the column and allow gel to settle in the column for
at least 30 min
e. Put a second porous disc on top of the settled gel bed and push down to just
above the settled gel. Leave 1-2 mm of space between the top of the gel bed and
the top disc. Do not compress the gel bed!
f. Wash the column with 10 volume of column buffer
g. Store the packed column upright at 4°C with gel bed submerged under 1-2
ml column buffer
10. Add 20 ml HEGX to the pellet and mix thoroughly by pipetting and vertexing.
Sonicate on ice for 10 cycles, 15 s for each cycle at output 6, 25% duty
11. Pellet the lysate at 15,000 rpm for 30 min at 4°C, transfer the supernatants to
a new bottle
12. Add 2.1 ml 10% neutralized PEI dropwisely on a magnetic stirrer.
13. Remove the precipitate by centrifuge at 12,000 rpm for 10 min at 4°C
14. Load the supernatant on a 5 ml chitin column. 7 ml at a time and incubate for
15min.
15. Wash the column at 0.2 ml/min with 100 ml HEGX.
16. Add 300 nmoles of the mixed and annealed Tn5MEDS + A/-B oligonucleotides
to the column in 6 ml degassed HEGX buffer. Leave the column at 4°C for 48 h.
17. Wash with 20 vol HEGX to remove free MEDS.
16. Add 14 ml HEGX and 100 mM DTT (7 ml 2x HEGX, 1.4 ml 1 M DTT, 5.6 ml
H20 to final 14 ml) to the top of the column bed. After 7 ml buffer drained out of the
column, keep the column closed for 36-48 h at 4°C
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17. Collect 14 fractions, 20 drops per fraction

Column regeneration: wash with 3 bed volumes of stripping buffer. Allow the resin
to soak for 30 min and then wash with an additional 7 bed volumes of stripping
buffer. Rinse with 20 bed volumes of water followed by 5 bed volumes of column
buffer. The resin can be stored at 4°C.

18. Run 25 µl of each fraction on SDS-PAGE.
19. Coomassie Staining:
Staining buffer: 0.2% coomassie, 50% methanol, 10% acetic acid
Destaining buffer: 40% methanol, 10% acetic acid
a. Rinse the gel with water once.
b. Add staining buffer and put in the microwave oven heat for 8s twice
c. Gentle rock on a shaker for 8~10 min
d. Destaining for several times until the band become clear.
e. Store the gel in water at 4°C
Staining buffer can be reuse for 4~5 times
20. Pool the fractions with highest concentration and dialysis versus two changes
of 1 L of 2x Tn5 dialysis buffer.
21. Concentrate the protein: Amicon Ultracel 30, 3000xg 20-25 min periods to a
final OD280 of at least 3.0 (35 µM).
22. Add 1.1 vol 99.5% glycerol and 0.33 vol of 2x Tn5 dialysis buffer (final 55%
Glycerol), and store at -20°C.
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